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Abstract 
Background: South Africa has a dual high burden of HIV and non-communicable diseases 
(NCDs). In a response to the dual burden of these chronic diseases, the National Department of 
Health (NDoH) introduced a pilot of the Integrated Chronic Disease Management (ICDM) 
model in June 2011 in selected Primary Health Care (PHC) facilities, one of the first of such 
efforts by an African Ministry of Health. The main aim of the ICDM model is to leverage the 
successes of the innovative HIV treatment programme for NCDs in order to improve the quality 
of chronic disease care and health outcomes of adult chronic disease patients. Since the initiation 
of the ICDM model, little is known about the quality of chronic care resulting in the 
effectiveness of the model in improving health outcomes of chronic disease patients. 
Objectives: To describe the chronic disease profile and predictors of healthcare utilisation 
(HCU) in a rural population in a South African municipality; and assess quality of care and 
effectiveness of the ICDM model in improving health outcomes of chronic disease patients 
receiving treatment in PHC facilities.  
Methods: An NDoH pilot study was conducted in selected health facilities in the Bushbuckridge 
municipality, Mpumalanga province, northeast South Africa, where a part of the population has 
been continuously monitored by the Agincourt Health and Socio-Demographic Surveillance 
System (HDSS) since 1992. Two main studies were conducted to address the two research 
objectives. The first study was a situation analysis to describe the chronic disease profile and 
predictors of healthcare utilisation in the population monitored by the Agincourt HDSS. The 
second study evaluated quality of care in the ICDM model as implemented and assessed 
effectiveness of the model in improving health outcomes of patients receiving treatment in PHC 
facilities. This second study had three components: (1) a qualitative and (2) a quantitative 
 xiv 
 
evaluation of the quality of care in the ICDM model; and a (3) quantitative assessment of 
effectiveness of the ICDM model in improving patients‘ health outcomes. The two main studies 
have been categorised into three broad thematic areas: chronic disease profile and predictors of 
healthcare utilisation; quality of care in the ICDM model; and changes in patients‘ health 
outcomes attributable to the ICDM model.  
In the first study, a cross-sectional survey to measure healthcare utilisation was targeted at 7,870 
adults 50 years and over permanently residing in the area monitored by the Agincourt HDSS in 
2010, the year before the ICDM model was introduced. Secondary data on healthcare utilisation 
(dependent variable), socio-demographic variables drawn from the HDSS, receipt of social 
grants and type of medical aid (independent variables) were analysed. Predictors of HCU were 
determined by binary logistic regression adjusted for socio-demographic variables.  
The  quantitative component of the second study was a cross-sectional survey conducted in 2013 
in the seven PHC facilities implementing the ICDM model in the Agincourt sub-district 
(henceforth referred to as the ICDM pilot facilities) to better understand the quality of care in the 
ICDM model. Avedis Donabedian‘s theory of the relationships between structure, process, and 
outcome (SPO) constructs was used to evaluate quality of care in the ICDM model exploring 
unidirectional, mediation, and reciprocal pathways. Four hundred and thirty-five (435) 
proportionately sampled patients ≥ 18 years and the seven operational managers of the PHC 
facilities responded to an adapted satisfaction questionnaire with measures reflecting structure 
(e.g. equipment), process (e.g. examination) and outcome (e.g. waiting time) constructs. 
Seventeen dimensions of care in the ICDM model were evaluated from the perspectives of 
patients and providers. Eight of these 17 dimensions of care are the priority areas of the HIV 
treatment programme used as leverage for improving quality of care in the ICDM model: supply 
 xv 
 
of critical medicines, hospital referral, defaulter tracing, prepacking of medicines, clinic 
appointments, reducing patient waiting time, and coherence of integrated chronic disease care (a 
one-stop clinic meeting most of patients‘ needs). A structural equation model was fit to 
operationalise Donabedian‘s theory using patient‘s satisfaction scores. 
The qualitative component of the second study was a case study of the seven ICDM pilot 
facilities conducted in 2013 to gain in-depth perspectives of healthcare providers and users 
regarding quality of care in the ICDM model. Of the 435 patients receiving treatment in the pilot 
facilities, 56 were purposively selected for focus group discussions. An in-depth interview was 
conducted with the seven operational managers within the pilot facilities and the health manager 
of the Bushbuckridge municipality. Qualitative data were analysed, with MAXQDA 2 software, 
to identify 17 a priori dimensions of care and emerging themes. In addition to the emerging 
themes, codes generated in the qualitative analysis were underpinned by Avedis Donabedian‘s 
SPO theoretical framework. 
A controlled interrupted time-series study was conducted for the 435 patients who participated in 
the cross-sectional study in the ICDM pilot facilities and 443 patients proportionately recruited 
from five PHC facilities not implementing the ICDM model (Comparison PHC facilities in the 
surrounding area outside the Agincourt HDSS) from 2011-2013. Health outcome data for each 
patient were retrieved from facility records at 30-time points (months) during the study period. 
We performed autoregressive moving average (ARMA) statistical modelling to account for 
autocorrelation inherent in the time-series data. The effect of the ICDM model on the control of 
BP (<140/90 mmHg) and CD4 counts (>350 cells/mm
3
) was assessed by controlled segmented 
linear regression analysis.  
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Results: Seventy-five percent (75%) of the 7,870 eligible adults 50+ responded to the health 
care utilization survey in the first study. All 5,795 responders reported health problems, of whom 
96% used healthcare, predominantly at public health facilities (82%). Reported health problems 
were: chronic non-communicable diseases (41% - e.g. hypertension), acute conditions (27% - 
e.g. flu), other conditions (26% - e.g. musculoskeletal pain), chronic communicable diseases (3% 
e.g. HIV and TB) and injuries (3%). Chronic communicable (OR=5.91, 95% CI: 1.44, 24.32) 
and non-communicable (OR=2.85, 95% CI: 1.96, 4.14) diseases were the main predictors of 
healthcare utilisation. 
Out of the 17 dimensions of care assessed in the quantitative component of the quality of care 
study, operational managers reported dissatisfaction with patient waiting time while patients 
reported dissatisfaction with the appointment system, defaulter-tracing of patients and waiting 
time. The mediation pathway fitted perfectly with the data (coefficient of determination=1.00). 
The structural equation modeling showed that structure correlated with process (0.40) and 
outcome (0.75). Given structure, process correlated with outcome (0.88). Patients‘ perception of 
availability of equipment, supply of critical medicines and accessibility of care (structure 
construct) had a direct influence on the ability of nurses to attend to their needs, be professional 
and friendly (process construct). Patients also perceived that these process dimensions directly 
influenced coherence of care provided, competence of the nurses and patients‘ confidence in the 
nurses (outcome construct). These structure-related dimensions of care directly influenced 
outcome-related dimensions of care without the mediating effect of process factors.   
In the qualitative study, manager and patient narratives showed inadequacies in structure 
(malfunctioning blood pressure machines and staff shortage); process (irregular prepacking of 
drugs); and outcome (long waiting times). Patients reported anti-hypertension drug stock-outs; 
 xvii 
 
sub-optimal defaulter-tracing; rigid clinic appointments; HIV-related stigma in the community 
resulting from defaulter-tracing activities; and government nurses‘ involvement in commercial 
activities in the consulting rooms during office hours. Managers reported simultaneous treatment 
of chronic diseases by traditional healers in the community and thought there was reduced HIV 
stigma because HIV and NCD patients attended the same clinic.  
In the controlled-interrupted time series study the ARMA model showed that the pilot facilities 
had a 5.7% (coef=0.057; 95% CI: 0.056,0.058; P<0.001) and 1.0% (coef=0.010; 95% CI: 
0.003,0.016; P=0.002) greater likelihood than the comparison facilities to control patients‘ CD4 
counts and BP, respectively. In the segmented analysis, the decreasing probabilities of 
controlling CD4 counts and BP observed in the pilot facilities before the implementation of the 
ICDM model were respectively reduced by 0.23% (coef = -0.0023; 95% CI: -0.0026,-0.0021; 
P<0.001) and 1.5% (Coef= -0.015; 95% CI: -0.016,-0.014; P<0.001). 
Conclusions: HIV and NCDs were the main health problems and predictors of HCU in the 
population. This suggests that public healthcare services for chronic diseases are a priority 
among older people in this rural setting. There was poor quality of care reported in five of the 
eight priority areas used as leverage for the control of NCDs (referral, defaulter tracing, 
prepacking of medicines, clinic appointments and waiting time); hence, the need to strengthen 
services in these areas. Application of the ICDM model appeared effective in reducing the 
decreasing trend in controlling patients‘ CD4 counts and blood pressure. Suboptimal BP control 
observed in this study may have been due to poor quality of care in the identified priority areas 
of the ICDM model and unintended consequences of the ICDM model such as work overload, 
staff shortage, malfunctioning BP machines, anti-hypertension drug stock-outs, and HIV-related 
stigma in the community. Hence, the HIV programme should be more extensively leveraged to 
 xviii 
 
improve the quality of hypertension treatment in order to achieve optimal BP control in the 
nationwide implementation of the ICDM model in PHC facilities in South Africa and, 
potentially, other LMICs.  
Keywords: Adults; predictors; healthcare utilisation; HIV; Chronic non-communicable diseases 
(NCDs); Primary Health Care (PHC); Health Outcomes; Integrated Chronic Disease 
Management (ICDM) Model; Avedis Donabedian; Quality of care; Structural equation model; 
Interrupted Time-Series; Segmented regression; multilevel regression; Agincourt HDSS study 
site; South Africa. 
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Preface 
―We need a comprehensive, integrated approach to service delivery. We need to fight 
fragmentation‖. 
Margaret Chan, Director General of the World Health Organization, 2007. 
 
―An Ideal Clinic is defined as a clinic with good infrastructure, adequate staff, adequate 
medicine and supplies, good administrative processes, and sufficient adequate bulk supplies. It 
uses applicable clinical policies, protocols and guidelines, and it harnesses partner and 
stakeholder support‖. 
National Department of Health, Republic of South Africa, 2015. 
 
There had been a global consensus that the vertically controlled HIV treatment programme 
resulted in fragmented chronic disease care; hence, the clamour led by Margaret Chan to fight 
this fragmentation through the integration of HIV and  NCD services. I was therefore extremely 
excited to discover that my PhD research was about monitoring chronic diseases and HIV 
progression and management in rural primary health care (PHC) in South Africa. This was an 
opportunity for me to conduct a study that would contribute to understanding chronic disease 
care by evaluating an intervention initiated to address the colliding epidemics of chronic non-
communicable diseases (NCDs) and HIV in South Africa.  
 
The timing of my PhD seemed appropriate because the NDoH in South Africa was ―re-
engineering‖ its PHC facilities, of which the Integrated Chronic Disease Management (ICDM) 
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model is a component. The ICDM model seeks to leverage the successes of the vertical HIV 
treatment programme for the poorly managed non-communicable diseases (NCDs) in order to 
improve the quality of care for NCDs with the expectation of improving health outcomes of 
chronic disease patients. Guided by my supervisors on arrival in South Africa, I commenced an 
extensive review of the literature on existing theoretical frameworks for evaluating health 
interventions. I was overwhelmed by the plethora of theoretical frameworks used to evaluate 
health interventions or health services and unsure which of these frameworks to adapt as my 
conceptual framework. Further literature search revealed that Avedis Donabedian‘s structure, 
process, and outcome framework, proposed in the 1960s, underpinned the planning and 
implementation of the pilot of the ICDM model in South Africa; hence, the rationale for 
adapting Donabedian‘s framework in evaluating the quality of care in the ICDM model in my 
PhD research. 
 
This encounter with the literature and constant guidance by my supervisors gave me a sense of 
how to develop a thesis protocol that focused on evaluating the quality of care in the ICDM 
model and the effectiveness of the ICDM model in improving patients‘ health outcomes.  
This thesis adopts a modern style (thesis with publications style) of thesis writing by 
incorporating an integrating narrative with four journal articles. The thesis presents the findings 
of the chronic disease profile in the population served by the health facilities in which the pilot 
of the ICDM model was implemented. Moving from the population to the public health 
facilities, this thesis also provides the results of an evaluation of the quality of care in the ICDM 
pilot facilities and the changes in patients‘ health outcomes attributable to the ICDM model. 
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This thesis is divided into two parts: part one is the integrating narrative which synthesises the 
results of all the thesis papers and their implications; while part two presents the four papers that 
make up this thesis. 
 1 
 
1.0 Introduction 
The World Health Organization (WHO) defines chronic diseases as those requiring ―ongoing 
management over a period of years or decades‖ covering a wide range of health problems 
expanding beyond chronic non-communicable diseases (NCDs) to include some communicable 
diseases such as the Human Immunodeficiency Virus (HIV) infection and the Acquired 
Immunodeficiency Syndrome (AIDS) (1). This is due to the recognition of the transformation of 
HIV/AIDS to a chronic condition as a result of increasing life expectancy which is an outcome of 
rapidly expanding roll-out of Antiretroviral Treatment (ART) (2, 3). 
 
South Africa has a dual high burden of HIV/AIDS and NCDs. The combined and growing 
epidemics of these chronic conditions have implications for South Africa‘s healthcare system 
which has yet to adapt to the long-term continuity of care for chronic diseases (4). The NDoH in 
South Africa introduced an integrated chronic disease management (ICDM) model in a response 
to the dual high burden of HIV/AIDS and NCDs. In 2011, a national pilot of the ICDM model 
commenced in selected Primary Health Care (PHC) facilities in three of South Africa‘s nine 
provinces, i.e. Gauteng, North West and Mpumalanga. The main aim of the ICDM model was to 
leverage the innovative HIV treatment programme for NCDs in order to improve the quality of 
chronic disease care and health outcomes of chronic disease patients. The ICDM model is a 
major initiative of the NDoH, one of the first of such efforts by an African Ministry of Health. 
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This thesis evaluated quality of care in the ICDM model and assessed effectiveness of the model 
in improving health outcomes of chronic disease patients receiving treatment in PHC facilities in 
the Bushbuckridge municipality situated in Mpumalanga province, northeast South Africa.  
1.1 Problem statement 
Societies experience an epidemiologic transition as they strive to achieve modernisation. 
Epidemiological transition, a concept developed by Abdel Omran in 1971, refers to transition 
from high mortality and fertility to low mortality and fertility as a country undergoes the process 
of modernisation from a developing nation to a developed nation (5). Omran described three 
―ages‖ in the process of modernisation: the ‗age of pestilence and famine,‘ ‗age of receding 
epidemics‘ and ‗age of degenerative and man-made diseases‘ (5). Many Low- and Middle-
Income Countries (LMICs) are at different ages of the epidemiological transition and the speed 
at which each country moves from one phase to another depends on country-specific 
geographical, cultural and socio-political factors.  
 
Modernisation and economic growth have engendered biomedical innovations leading to the 
replacement of infectious diseases with chronic conditions. The latter are due to increasing life 
expectancy which is stimulated by improved public health services; water and environmental 
sanitation; and increasing socio-behavioural risk factors such as tobacco use, physical inactivity, 
harmful use of alcohol and unhealthy diet.  
 
However, Omran‘s theory of sequential transition from one age to another was stalled or even 
reversed due to the HIV/AIDS epidemic in sub-Saharan Africa (6), with some countries 
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experiencing a high mortality at younger ages. The expanded use of Anti-Retroviral Treatment 
(ARTs) increased life expectancy which is defined as the probable number of years a person will 
live after a given age as determined by the mortality rate in a given geographic area (7). 
Consequently, there has been a rise in the burden of age-associated non-communicable co-
morbidities (AANCC) among people living with HIV (PLWHIV) comparable to the general 
population  (2, 3). On the other hand, some opportunistic illnesses associated with HIV 
infections (e.g. cervical cancer) are NCDs in their own right (2). Hence, African countries are 
witnessing an increasing dual burden of NCDs and HIV.  
 
Non-communicable diseases are currently the leading cause of death globally (8). Nearly three-
quarter of these deaths occur in LMICs (8) which have age-adjusted mortality rates nearly twice 
that of high-income countries (9). Mortality due to NCDs will increase in the next two decades 
(10) with Africa having the greatest increase (11).  
 
Since the beginning of the HIV/AIDS epidemic, over 78 million people have been infected with 
the virus and 39 million people have died of AIDS (12); thereby, making HIV/AIDS one of the 
most explosive epidemics the world has ever witnessed. In 2011, nearly 70% of the 34 million 
PLWHIV worldwide resided in SSA (12).  
 
Similar to some African countries, South Africa is experiencing a dual burden of HIV and NCDs 
which have been described as diseases on a collision course (13). In 2014, the prevalence of HIV 
in South Africa was estimated at 10%, one of the highest in Africa (14) while NCDs accounted 
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for 43% of all deaths (15). The high NCD-related mortality in South Africa has been attributed to 
poor management of NCDs within the healthcare system (16, 17) and fragmented chronic 
diseases services (4, 18). It has been reported in the literature that poor management of NCDs is 
a consequence of non-systematic implementation of treatment guideline; non-consultative 
process with relevant stakeholders in the development of guidelines; skepticism about durability 
of the guideline; conflict with local practices; health system problems and patient beliefs (16). 
Patients‘ poor knowledge of their conditions and drug prescriptions not being recorded in the 
medical records have also been identified as factors adversely affecting optimal management of 
NCDs (17). The high morbidity/mortality associated with NCDs and the fragmentation of 
chronic disease care have implications for South Africa‘s public healthcare system which has yet 
to adapt to the long-term continuity of care for chronic diseases (4, 18).  
 
Tackling the dual burden of HIV/AIDS and NCDs seems feasible due to the commonalities that 
are related to their progression; prevention; and control. For instance, HIV and NCDs have 
minimal or no symptoms at early stages of onset, thus requiring a model of care different from 
acute care model. Both HIV and NCDs require ongoing clinic appointment/attendance, 
adherence to medication, necessitating approaches such as developing appropriate appointment 
and medication reminder systems, adherence, community follow-up, self-management and 
referrals (2).  
 
Following the evidence that integrated chronic disease care improves patient‘s health outcomes 
and minimises HIV-related stigma (19), the Joint United Nations Programme on HIV/AIDS 
(UNAIDS) recommends an integrated approach for chronic disease management (2), using the 
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building blocks described in the Innovative Care for Chronic Conditions (ICCC) framework (1). 
In a response, the NDoH in South Africa initiated the Integrated Chronic Disease Management 
(ICDM) model which is a component of the PHC reengineering strategy to strengthen the public 
healthcare system. (20-22). The ICDM model adopts a diagonal approach in leveraging the 
innovations of the vertical HIV programme for scaling up or supporting services for NCDs (22). 
Such innovations include programme approaches (peer programmes, defaulter tracing 
initiatives, multidisciplinary teams, and community engagement); tools (registers, charts, forms 
and medical records) and systems (monitoring and evaluation, improving quality, supply chain 
and procurement, referring people and processing of specimens) (2). 
 
Following the initiation of the pilot of the ICDM model in South Africa, there is a paucity of 
published literature on the effectiveness of the model in improving the quality of integrated 
chronic care and health outcomes of chronic disease patients.   
   
1.2 Study justification 
Initiation of the ICDM model as a response to the dual high burden of HIV and NCDs in South 
Africa presents an urgent necessity to better understand how the model works. Although a pilot 
study in Cambodia demonstrated the feasibility of an integrated care for HIV and NCDs (2, 19), 
there is a pressing need for local data on an integrated chronic disease approach in Africa given 
the socio-economic and geo-cultural differences across settings.  
In Uganda, a multidisciplinary initiative for integrated management of NCDs was formed in 
2013 with an aim of reframing integrated health service delivery, but there was no data to show 
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the feasibility of this initiative in improving the quality of integrated chronic care and health 
outcomes of chronic disease patients (23).  
 
Two proof-of-concept pilot studies to further understand the status of NCD services and the 
feasibility and effectiveness of adapting HIV programme-related tools and systems for patients 
with diabetes mellitus (DM) have been conducted in health facilities in Swaziland and Ethiopia 
(24). Significant gaps in the strategies, systems and tools used to support DM services in both 
countries were identified and a continuum of approaches in leveraging HIV programme for 
NCDs was recommended to implementers and policy makers. These approaches included 
integration of chronic disease services, parallel ―side-by-side‖ services for the longitudinal 
management of all chronic diseases, and an intermediate approach in which clinical services are 
not integrated, but the systems behind these services (e.g. use of guidelines, training, 
procurement of drugs and supplies, laboratory systems, and monitoring and evaluation) are 
shared (24). Although data on process indicators were measured, there was a dearth of 
information on the health outcomes of both HIV and DM patients to identify opportunities for 
diffusion of innovations in the HIV programme. 
 
In South Africa, little is known about the effectiveness of the ICDM model in improving the 
quality of chronic disease and health outcomes of patients since initiation of the model as a pilot 
programme in 2011. This study will add to the existing body of knowledge by contributing to the 
national and global debate on the feasibility of leveraging the successes of the innovations of the 
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HIV treatment programme to support or scale-up services for NCDs, particularly in LMICs, by 
evaluating the ICDM model used in South Africa. 
1.3 Hypothesis, research aim, and research objectives 
1.3.1 Hypothesis 
I hypothesise in this thesis that the ICDM model has led to changes in key health outcome 
indicators of patients (e.g. blood pressure (BP) and CD4 counts) since the model was 
implemented in 2011 in selected PHC facilities in the rural Bushbuckridge municipality of 
Mpumalanga province.  
1.3.2 Research aim 
1. To profile chronic diseases and determine the predictors of healthcare utilisation by 
adults 50 years and older in the population; evaluate the quality of care provided in the 
ICDM model implemented in selected PHC facilities in a rural South African setting; and 
assess the effectiveness of the model in improving key health outcomes of patients 
receiving treatment for chronic diseases. 
1.3.3 Research objectives 
1. To profile chronic diseases and determine the predictors of healthcare utilisation by adults 
50 years and older in the population in 2010, the year before the ICDM model was 
initiated. 
2. To evaluate the quality of care provided in the ICDM model in 2013.  
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3. To assess the perception of patients (P) and operational managers (OM) regarding quality 
of care in the ICDM model in 2013. 
4. To assess the effectiveness of the ICDM model in controlling patients‘ CD4 counts 
(>350cells/mm3) and blood pressure (<140/90 mmHg) from 2011 to 2013. 
1.4 Thesis themes 
1.4.1 Overall theme  
The overarching theme in this thesis is an evaluation of the ICDM model which was initiated as 
a response to the dual burden of HIV and NCDs in South Africa, a LMIC undergoing a rapid 
health transition. 
1.4.2 Specific themes 
1. Chronic disease profile and predictors of healthcare utilisation: This theme describes the 
main chronic diseases and predictors of healthcare utilisation among adults ≥ 50 years in the 
year before the ICDM model was initiated. This population profile of chronic diseases 
provides a sense of what is to be expected in the PHC facilities where these adults seek 
healthcare. 
2. Quality of care in the ICDM model: This theme has quantitative and qualitative components 
that contribute to understanding the quality of care in the ICDM model which determines the 
effectiveness of the model in improving key indicators of patients‘ health outcome.    
3. Changes in patients‘ health outcomes attributable to the ICDM model: Objective assessment 
of the changes in patients‘ health outcomes provides a better understanding of the 
 9 
 
effectiveness of the ICDM model in impacting the health of patients for whom the model 
was intended.  
 
Table 1: Relationship between the thesis themes, research objectives and the papers responding 
to the research objectives 
 
Themes and research objectivess 
Papers 
I II III IV 
Theme 1: Chronic disease profile and 
predictors of healthcare utilisation  
 
Research objective 1: 
What were the main chronic diseases and 
predictors of healthcare utilisation by adults 50 
years and older in 2010 the year before the ICDM 
model was initiated? 







 







 
 
 
 
 
 
 

 







 
Theme 2: Quality of care in the ICDM model  
 
Research objective 2 (Quantitative method): 
What was the quality of care in the ICDM model? 
 
 
Research objective 3 (Qualitative method): 
How did the patients and operational managers 
perceive the quality of chronic disease care in the 
ICDM model?  
 








 









 
 
Theme 3: Changes in patients’ health outcomes 
attributable to the ICDM model  
 
Research objective 4: 
Was the ICDM model effective in controlling 
patients‘ CD4 count (>350cells/mm3) and blood 
pressure (<140/90 mmHg)? 
   






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1.5 Conceptual framework 
Figure 1 shows the conceptual framework for this PhD thesis. It was adapted from the WHO‘s 
Innovative Care for Chronic Conditions (ICCC) framework (1), which also underpins the ICDM 
model developed by the NDoH in South Africa (20). The ICCC framework acknowledges that 
healthcare services for chronic conditions are inherently different from healthcare services for 
acute problems; therefore, acute care models cannot be applied to chronic disease care. The 
framework highlights the hierarchical levels of interaction between relevant stakeholders, roles 
and activities of stakeholders, and expected outcomes of these interactions all of which are 
necessary for long-term continuity of care for the management of chronic conditions.  
 
The micro-, meso-, and macro-levels of healthcare refer to the patient interaction level, the 
healthcare organisation/community level and the policy level, respectively (1). These levels are 
described as building blocks that can be used to create or redesign a healthcare system that can 
more effectively manage long-term health problems. At the micro-level, optimal outcomes occur 
when there is a triad of partnership between patients and families, healthcare teams, and 
community supporters, with an underlying notion that each member of the triad needs to be 
informed, motivated and prepared to manage chronic diseases.  Furthermore, the framework 
recognises increased attention to patient behaviour as well as healthcare worker communication 
for optimal health outcomes. At the meso-level, community resources must be integrated to 
make significant gain, while healthcare organisations need to streamline services, build capacity 
of the health workforce, focus on prevention, and establish a reliable health information tracking 
system for patients receiving treatment for chronic conditions. Governments need to guide 
policy-making and set standards for quality of care at the macro-level.  
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The interactive feedback loops in the roles and activities of stakeholders at various levels 
highlight how events at one level influence actions and events at another level. For instance, 
patients‘ interaction with health workers at the micro-level may elicit responses from healthcare 
organisation/community at the meso-level. The latter are responsive to policies at the macro-
level which in turn influence patients at the micro-level and the feedback loops perpetuate. 
 
Interactions between stakeholders at various levels are expected to produce outcomes; conducive 
policy environment, better quality of care and optimal patient health outcomes at the macro-, 
meso-, and micro-level, respectively. Further details of the ICCC framework have been provided 
in the literature review section as one of the initiatives to reduce chronic disease burden. 
 
This thesis, through the three green-coloured oval-shaped callout bubbles in Figure 1, assessed 
and/or evaluated the expected outcomes of the hierarchical levels of interaction between relevant 
stakeholders in the pilot implementation of the ICDM model: availability of and an analysis of 
an ICDM policy to create an enabling environment for the operational implementation of the 
ICDM model (macro-level), quality of care in the health facilities (meso-level) and optimal 
patient health outcomes (micro-level).  
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Figure 1: A conceptual framework for evaluating the ICDM model used to address South Africa‘s dual burden of HIV and NCDs. 
Adapted from the WHO‘s Innovative Care for Chronic Conditions (ICCC) framework (1)
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2.0 Literature review 
This section presents a review of the literature on the epidemiologic transition theory that 
underpins the dual burden of HIV and NCDs in LMICs and South Africa, initiatives to 
strengthen health systems, and strategies to reduce chronic disease burden. Subsequent sections 
highlight South Africa‘s core quality standards; the link between the ICDM model and the 
national core quality standards; the link between the ICDM model and the Primary Health Care 
(PHC) re-engineering initiative of South Africa‘s NDoH and theoretical frameworks for 
evaluating health interventions. 
2.1 Epidemiological transition in low- and middle-income countries 
Several LMICs are at different stages in their epidemiological transition.  However, the speed at 
which each country transits depends on context-specific geographical, cultural and socio-
political factors. In the 1950s, progress was slow in countries barely out of the ―age of pestilence 
and famine‖ where life expectancy was low. This was because the advances in the control of 
infectious diseases benefited only a fraction of the population, mostly urban (25). At a later 
stage, life expectancy increased because the health systems reached their full capacity to contain 
widespread endemic diseases, as was the case in Chile and Korea. However, as these LMICs 
moved closer to life expectancy levels reached in high-income nations, the pace slowed again in 
the 1980s because there was no longer much to be gained in the field of infectious diseases (25). 
Although Tunisia in north Africa continued to make gains in life expectancy, the pace slowed 
drastically in Zimbabwe, Zambia, Botswana, Rwanda, Namibia in southern Africa and Uganda 
in east Africa with the arrival of the HIV/AIDS epidemic (Figure 2) (26). In South Africa, the 
HIV/AIDS epidemic significantly contributed to the drastic reduction in life expectancy from 62 
years in 1990 to 50 years in 2007, when the use of ARTs started to became more available (27). 
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However, there has been a significant reduction in population-level mortality following the roll-
out of ARTs in South Africa in 2014 (28) and other sub-Saharan African countries (29, 30).  
 
Figure 2: Changes in life expectancy since the 1950s: North-South convergences (A) and South-
South divergences (B) 
Source: United Nations 2001 (25) 
 
 
2.1.1 Epidemiological transition in South Africa 
In South Africa, there is an emergence of a pattern of multi-morbidity (co-existence of more than 
one chronic disease) different from that previously described in the literature. This is referred to 
as comorbid non-communicable and infectious chronic diseases (e.g. TB) and is common in 
younger age due to the high prevalence of HIV/AIDS in young people (31). These multi-
morbidities have been attributed to increasing life expectancy due to ART roll-out; and the risk 
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of dysglycaemia (32) and cardiometabolic syndrome (33) associated with some antiretroviral 
drugs.  
 
Use of ART is not the only contributor to the epidemiological transition reported in many 
LMICs. Obesity has also been reported as a major contributor to the emergence of diet-related 
NCDs (e.g. cardiovascular diseases and diabetes) in adults (34). Childhood obesity has also been 
reported in South Africa (Kimani) and other LMICs (Kelishadi 8), and is a driving force behind 
the emergence of cardiovascular complications, and type I and type II diabetes (Reilly 9). Of 
further concern is the fact that obese children are likely to become obese adults; hence, fueling 
the epidemic of NCDs and the attendant cardiometabolic syndrome over time (Reilly 9).   
2.2 Burden of chronic communicable and non-communicable diseases 
Chronic non-communicable diseases (NCDs) are responsible for two-thirds of all mortalities 
worldwide, with 80% of these deaths occurring in LMICs (8). The total annual number of deaths 
from NCDs is estimated to increase to 55 million by 2030 (10), with Africa having the greatest 
increase of 27% (11). NCDs will have a remarkable impact on the world's overall disease burden 
and healthcare because they are the leading cause of mortality in six middle-income countries 
(China, Ghana, India, Mexico, Russia, and South Africa) that host 42% of the world's 1.4 billion 
people aged 50 years and older. South Africa has the highest prevalence of hypertension among 
these countries (35). 
 
But chronic conditions are not limited to NCDs alone. There is increasing recognition of the 
transformation of chronic communicable diseases such as Human Immunodeficiency Virus 
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(HIV) to a chronic condition due to rapidly expanding Antiretroviral Treatment (ART) which 
fuel the emergence of age-related chronic conditions (2, 3). Chronic diseases now include all 
health problems that require ongoing management over a period of years or decades expanding 
beyond the traditional NCDs to include HIV (1).  
 
In South Africa, there is a dual burden of HIV/AIDS and NCDs (13). In 2014, NCDs accounted 
for 43% of all deaths (15) and the overall prevalence of HIV was estimated at 10.2% (14); 
making South Africa the country with highest HIV prevalence in Africa. The main NCDs in 
South Africa are hypertension and diabetes mellitus with reported prevalence of 78% (36) and 
7% (37) in the adult population. The combined epidemics of HIV and NCDs have implications 
(e.g. overburdened infrastructure) for South Africa‘s public healthcare system which is yet to 
adapt to the long-term continuity of care for chronic disease patients. The challenge posed to the 
overburdened and weakened public healthcare system by these chronic diseases demands an 
extraordinary response (38). Given the increasing burden of chronic diseases which require a 
chronic care model for long term continuity of care, it is crucial to strengthen the already 
overburdened and weakened healthcare systems for improved health outcomes of chronic disease 
patients. The next section highlights international and national initiatives to strengthen health 
systems and tackle chronic disease burden.  
2.3 Health system strengthening 
In rethinking the link between health and development, arguments were made by the World 
Bank in the 1990s in favour of a policy on increased investment in the health system (39). The 
health sector therefore became a prime target for reforms based on the ideological assumption 
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that market-based systems are the most efficient ways to produce and distribute healthcare (40). 
Although this policy led to improvements in human development indices in many high income 
countries, it resulted in health inequality and worsened poverty levels in many LMICs (40).  
Following, at least, a decade of huge investments, there was a paradigm shift from market-
oriented health systems to the notion of health system strengthening having realised that market-
based systems will not automatically protect poor people or guarantee universal access to 
healthcare (41).  
 
2.3.1 A health system framework 
The WHO defines a health system as consisting of all organisations, people and actions whose 
primary intent is to promote, restore or maintain health (42). In 2007, the WHO developed a 
framework for action to address the urgent need to improve performance of health systems. This 
framework has six building blocks: service delivery; health workforce; information; medical 
products, vaccines and technologies; financing; and leadership and governance (Figure 3). These 
six building blocks are considered necessary to improve outcomes through desirable attributes 
such as access, coverage, quality and safety. These building blocks also seek to identify WHO‘s 
priorities and provide a means of identifying gaps for addressing county-specific challenges.  
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Figure 3: The six building blocks of a health system  
Source: World Health Organization 2007 (42)  
 
However, addressing country-specific health system challenges may not be feasible using the 
simplistic approach outlined in the WHO‘s distinct building blocks (42). A pragmatic response to 
health system challenges facing many countries should recognise the interactions and 
interrelationships between the six building blocks of the health system and between the various 
individuals within the health system (Figure 4). In 2009, de Savigny et al. offered a fresh and 
practical approach to strengthening health systems through ―systems thinking‖ when they stated 
that “the building blocks do not constitute a system any more than a pile of bricks constitutes a 
functioning building. It is the multiple relationships and interactions among the blocks – how 
one affects and influences the others, and is in turn affected by them – that converts these blocks 
into a system” (43). They emphasised that health systems are often seen as a monolith in which 
little attention is paid to the interactions among its component parts. de Savigny et al.  suggested 
a people-centred health system in which individuals, civil society organisations and stakeholder 
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networks are placed at the centre of the health system framework and are key actors with health 
workers, managers and policy makers in influencing each of the building blocks of the health 
system (43). Health systems are shaped by both structural or hardware (e.g. organizational, 
policy, legal and financing frameworks) and social or software (e.g. norms, traditions, values, 
roles and procedures) elements of the health system, which in turn, influence health system 
performance (44). In order to identify actions to strengthen health systems, researchers and 
policy-makers should consider making changes that are likely to improve health systems 
performance by targeting its hardware and software components (44).  
 
Figure 4: The interconnections among the building blocks of a health system  
Source: de Savigny and Adam, 2009;32 (43) 
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2.3.2 Primary health care (PHC) re-engineering 
With the growing recognition that the health-related MDGs will not be met by September 2015 
without improving the health system (45) through primary health care approach (41), a PHC 
strategy has been applied as the health system‘s organisational strategy and underlying 
philosophy in South Africa (46). There is evidence that strengthened primary level of care leads 
to improved population health in LMICs such as Brazil, Costa Rica and Cuba (47). Lessons 
learned from Brazil informed the NDoH in South Africa to re-engineer its PHC system (48). The 
PHC re-engineering framework of the NDoH is shown in Figure 5.  
 
The PHC re-engineering currently underway in South Africa consists of three streams: a District 
Clinical Specialist Team (DCST) to strengthen referral mechanism between PHC clinics and 
referral hospitals; a Ward-based Outreach Team (WBOT) consisting of professional nurses, 
enrolled nurses and community health workers (CHWs) interacting directly with the community 
to conduct health education campaigns as well as primary prevention through screening of high-
risk individuals; and an integrated school health programme (ISHP) to assist with early detection 
of chronic diseases and the appropriate referral of these high-risk patients (20). Ongoing efforts 
in this initiative should ensure that the composition of a defined comprehensive primary care 
package of services extend beyond services traditionally provided in health facilities. With 
CHWs playing a key role, the services which are aimed at reducing health inequality should now 
be population-oriented with extensive community outreach and home-based services (20). The 
next section presents specific initiatives to reduce chronic disease burden. 
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Figure 5: The primary health care re-engineering framework based on the district health model 
Source: The Integrated Chronic Disease Management Manual 2014 (20) 
 
2.4 Health service delivery initiatives to reduce chronic disease burden 
2.4.1 The innovative care for chronic conditions (ICCC) framework 
The ICCC framework was introduced by the WHO in 2002 (1) as an expansion of an earlier 
model, the Chronic Care Model, which was developed by Wagner et al. in the mid-1990s to 
present a structure for organising healthcare for chronic conditions (49). Innovation in healthcare 
for chronic conditions is the introduction of new ideas, methods, or programmes to change the 
way chronic conditions are prevented and managed (1). The healthcare perspective of this 
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framework is that chronic diseases should not be viewed as discrete problems or according to the 
traditional categories of communicable and non-communicable diseases. Innovative care is not 
based on the aetiology of a chronic condition, but is based on the demands that the health 
problem places on the health system. Such demands entail reorienting healthcare systems in a 
way that outcomes valued by the system are the ones that are produced.  
 
The ICCC framework recognises that patients‘ needs transcend biomedical interventions. 
Patients need integrated care that cuts across time and settings. Innovative care recognises that 
patients and their families can most effectively manage chronic conditions with the support of 
their healthcare teams and their communities. Each entity needs to be linked and each is 
integrally important to the other in a manner that patients, communities and healthcare 
organisations each have important roles to play in improving outcomes for chronic conditions.  
 
In this regard, innovation in care for chronic conditions is the integration of ―building blocks‖ 
from the micro-, meso- and macro-levels of the health system by leveraging the previous 
successes of the HIV/AIDS programme into better care for other chronic conditions (Figure 6). It 
must be acknowledged that the ICCC‘s building blocks are different from the WHO‘s six 
building blocks. The triad at the centre of the ICCC framework represents the micro-level and 
consists of informed, motivated and prepared partnership of patient and family, community 
partners and healthcare team working together to achieve positive outcomes for chronic 
conditions. The meso- and macro-levels are respectively the community resources and policy 
framework that enable the triad of the patient/family, community partners and healthcare team to 
function at its best.   
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Figure 6: The innovative care for chronic conditions framework 
Source: World Health Organization 2002 (1) 
2.4.2 The Integrated Chronic Disease Management (ICDM) model  
Integrated healthcare has multiple meanings and usages, and has been a source of polarised 
debate (45). Some examples of integrated health service include: combining two or more 
disease-specific care at one service delivery point (e.g. integrated management of childhood 
illness); continuity of care over time across different levels (appropriate referral system); 
integrating disease-specific (vertical) programmes with general healthcare system; multi-sectoral 
collaboration; or even a combination of all of these (45). The World Health Organization (WHO) 
defines integrated healthcare as “the organisation and management of health services so that 
people get the care they need, when they need it, in ways that are user-friendly, achieve the 
desired results and provide value for money‖ (45).  
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The Joint United Nations Programme on HIV/AIDS (UNAIDS) recommends a globally 
comprehensive and integrated approach to the delivery of chronic disease care. This approach 
requires leveraging the successful HIV programme innovations to support or scale-up services 
for NCDs (2, 50) in the context of the ICCC framework (1). Beyond the UNAIDS mandate for 
the implementation of an integrated chronic care model, integrating services for HIV and NCDs 
could also minimise fragmented chronic disease care arising from the management of the HIV 
pogramme in a ‗silo‘ within the general healthcare system, leverage resources and more 
efficiently meet patients‘ healthcare needs (4, 13, 38).  Evidence from the Cambodian pilot study 
on integrating services for HIV with hypertension and diabetes showed increased CD4 count, 
reduced blood pressure and reduced stigma (19). However, high mortality and low median CD4 
counts were reported early in the study and this was attributed to large number of PLWHIV not 
having access to HARRT. Another limitation of the Cambodian study was that almost 30% of 
diabetes patients were lost to follow up in the first three months due to the perception that 
diabetes is not a life threatening condition and use of alternative care through private providers 
(19).  
 
In heeding the UNAIDS‘ recommendation, the NDoH in South Africa initiated the ICDM model 
as part of the effort to re-engineer its PHC system. ―The ICDM model is a model of managed 
care that provides for integrated prevention, treatment and care of chronic patients at PHC level 
to ensure a seamless transition to ―assisted‖ self-management within the community‖. The aim of 
the ICDM is to improve the quality of chronic disease management and achieve optimal clinical 
outcomes for patients with chronic communicable and non-communicable diseases using the 
health system building blocks approach (20). 
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The pilot study of the ICDM model was commenced in June 2011 in selected PHC facilities in 
three of South Africa‘s nine provinces (Gauteng, North West and Mpumalanga) (20). At the crux 
of the ICDM operational framework are facility reorganisation and clinical management support 
to improve operational efficiency and quality of care at the facility level; ―assisted‖ self-
management to promote individual responsibility at the community level; and health promotion 
and population screening in the population to increase the awareness of chronic diseases at the 
population level (Figure 7) (20).  
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Figure 7: The integrated chronic disease management (ICDM) model  
Source: National Department of Health 2014 (20) 
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The facility component entails many areas of focus such as: designation of chronic care area; use 
of guidelines for management of chronic diseases; human resource audit; capacity building; 
supply of critical medicines; prepacking of medication; and appropriate referral. To prepare the 
community for chronic disease care, each clinic has a ward-based outreach teams (WBOT) 
operating within the community that the clinic serves, and consists of one professional nurse, 
three staff nurses, and six Community Health Workers (CHWs). It is anticipated that at least 
80% of defined health problems of the catchment population would be managed with the 
outreach team responsible for 6000 individuals in 1500 households (250 households per 1 CHW) 
(20). The ICDM model addresses the following disease categories: HIV/AIDS, tuberculosis, 
hypertension, diabetes, chronic obstructive pulmonary disease, asthma, epilepsy and mental 
health illnesses that are to be managed at PHC level (20).   
2.4.3 The ideal clinic 
The ideal clinic programme was initiated by the NDoH in July 2013 and launched on 18 
November 2014 to further support the PHC reengineering of which the ICDM model is a 
component (51, 52). The aim of the ideal clinic is to improve the quality of care, including 
chronic disease services through the ICDM model, offered in PHC facilities. An ideal clinic is 
defined as a clinic with good infrastructure, adequate staff, adequate medicine and supplies, good 
administrative processes, and sufficient adequate bulk supplies An ideal clinic uses applicable 
clinical policies, protocols and guidelines, and it harnesses partner and stakeholder support. All 
these contribute to the provision of good quality health services to the community (52).  
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The Ideal Clinic Realisation and Maintenance (ICRM) segment of the Operation Phakisa 
initiative, which has ocean economy and health components, seeks to transform all public sector 
clinics into ideal clinics which will provide good quality care to all communities. Operation 
Phakisa was derived from Malaysia‘s Big Fast Results Methodology through which the 
Malaysian government achieved significant economic transformation within a very short time by 
addressing poverty, crime and unemployment. With the support of the Malaysian government, 
the Big Fast Results approach was adapted to the South African context. In highlighting the 
urgency of its delivery, the approach was renamed Operation Phakisa (―phakisa‖ means ―hurry 
up‖ in Sesotho language) with the purpose of fast tracking the implementation of South Africa‘s 
National Development Plan (51, 52). A national overview of ideal clinic status determination 
was conducted in 2015 among 962 facilities representing 85% of the total facilities in South 
Africa. The best-performing province was the Eastern Cape, while the worst-performing 
provinces were Mpumalanga (where the study setting of this research is situated in), Free State, 
Northern Cape and Limpopo (52).  
2.5 The National Core Quality Standards  
The national core quality standards for health establishments in South Africa was revised in 2010 
by the NDoH with support from its national and provincial staff and private sector partners. The 
main purpose of the national core quality standards is to develop  a common definition of quality 
of care, which should be found in all health establishments in South Africa as a guide to the 
public and to managers and staff at all levels; establish a benchmark against which health 
establishments can be assessed, gaps identified, strengths appraised; and provide a national 
framework to certify health institutions as compliant with standards (53). The standards have 
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been developed into seven cross-cutting domains where service quality or safety can be at risk 
(Figure 8).  
 
Figure 8: The seven domains of the National Core Quality Standards 
Source: National Department of Health, 2011 (53) 
2.6  Overlaps between the ICDM model and the national core quality 
standards 
The NDoH identified six priority areas of the core quality standards to fast-track improvement in 
the delivery of health services generally. These include: improving staff values and attitudes; 
waiting times; cleanliness; patient safety and security; infection prevention and control; and 
availability of medicines and supplies (Figure 9). The purpose of the ICDM model is to more 
specifically improve the quality of chronic disease care. This requires ensuring implementation 
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of, or compliance with, the core quality standards. Hence, the ICDM model addresses the six 
priority areas of the national core quality standards (20). 
 
Figure 9: Overlaps between ICDM model and the six priority areas of the national core quality 
standards 
Source: National Department of Health 2014 (20) 
 
2.7  Overlaps between the ICDM model and PHC re-engineering 
framework  
The ICDM model is a component of the ongoing PHC re-engineering framework designed to 
strengthen South Africa‘s health system at the primary care level. The ICDM model integrates 
and works synergistically with the three streams of the PHC re-engineering framework (Figure 
10). The DCST exercises oversight over the quality of care by mentoring and supervising the 
process of care provided and undertakes clinical audits of the professional healthcare workers‘ 
services (20). The WBOT ensures continuity of care by interacting directly with the community 
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during which health education campaigns and primary prevention through screening of high-risk 
individuals will be conducted. The WBOT visits at-risk households to provide or support 
―assisted‖ self-management, do secondary health promotion, and identify complications that 
require referral to PHC facilities (20). The ISHP teams conduct education and awareness 
campaigns at the schools, provide screening services for the early detection of chronic diseases 
and refer these high-risk patients to PHC facilities (20). In addition to these three streams, the 
district management team performs an oversight and stewardship role in monitoring the 
implementation of the ICDM model and addresses systemic challenges that impede the 
implementation process and service delivery (20).  
 
 
 
Figure 10: Overlaps between integrated chronic disease management and the primary health care 
re-engineering framework 
Source: National Department of Health 2014 (20) 
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2.8 Theoretical framework for evaluating the ICDM model   
 ―Quality of medical care‖ is highly contextual and a difficult concept to define.  Although it is a 
reflection of values and goals in the medical care system and in the larger society which it is a 
part of, quality can be almost anything anyone wishes it to be (54). Klein et al. conclude that 
patient care, like morale, cannot be defined by a unitary concept and that it seems unlikely that 
there will be a single criterion by which to measure the quality of patient care (55). The 
subsequent paragraphs in this section describe some theoretical frameworks that were considered 
for evaluating the ICDM model and their advantages and disadvantages. 
 
In 1966, Avedis Donabedian described seven elements of quality of medical care: efficacy, 
effectiveness, efficiency, equity, optimality, acceptability and legitimacy (56). Efficacy is the 
care provided under optimal conditions. Although it is not measurable in real life, efficacy is the 
basis against which measurements are made. Effectiveness refers to the outcome of interventions 
when the interventions are implemented as they would be in real life; efficiency speaks to the 
reduction of costs without compromising effects; equity is the fairness in which healthcare is 
distributed among populations and among some specific groups within these populations; 
optimality refers to balancing the costs and benefits of healthcare; acceptability encompasses 
sub-elements, such as interpersonal patient-provider interaction and accessibility of healthcare; 
and legitimacy is the social acceptability of the healthcare institution. The choice and relative 
prioritisation of these elements should be contextual and guided by the circumstances in which 
quality of care is assessed (56).  
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Avedis Donabedian postulated that there are relationships between structure, process and 
outcome (SPO) constructs based on the premise that good structure should promote good process 
and good process should in turn promote good outcome (unidirectional pathway). The SPO 
framework, often represented by a chain of three boxes containing SPO constructs connected by 
arrows (56), can be used to draw inferences about the quality of healthcare (57). Donabedian 
defines ―structure‖ as the professional and organisational resources associated with the provision 
of healthcare (e.g. availability of medicines/equipment and staff training); ―process‖ as the things 
done to and for the patient (e.g. defaulter tracing and hospital referrals) and ―outcome‖ as the 
desired result of care provided by the health practitioner (e.g. patient satisfaction with quality of 
care). Donabedian distinguished between two types of outcomes: i) technical outcomes, which 
are the physical and functional aspects of care, such as absence of complications and reduction in 
disease, disability and death; and  ii) interpersonal outcomes which include the patients‘ 
satisfaction with care and  influence of care on patients‘ quality of life as perceived by the patient 
(58).  
 
This research used Avedis Donabedian‘s SPO framework to evaluate the ICDM model. This is 
because Donabedian‘s SPO theory is the touchstone and dominant framework for evaluating the 
quality of medical care (59) and because the SPO framework is used by South Africa‘s National 
Department of Health for the implementing the ICDM model (20). Another justification for 
selecting Donabedian‘s framework is because it overlaps considerable with four domains 
outlined in the WHO‘s framework (effectiveness, efficiency, equitability and acceptability). 
Moreover, researchers from Sweden showed statistically significant relationships between SPO 
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constructs using Donabedian‘s theory in a study of quality systems conducted among department 
managers and quality coordinators in 386 hospitals(60).  
 
To my knowledge, this is the first study to apply Donabedian‘s theory in evaluating the quality 
of care in the ICDM model in South Africa.  
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3.0 Methodology 
3.1 Study setting and population 
3.1.1 Physical and demographic characteristics 
This research was conducted in the Bushbuckridge municipality, Mpumalanga Province, 
northeast South Africa. The health and demographic patterns of the population in the Agincourt 
sub-district in the Bushbuckridge municipality have been monitored since 1992 by the 
MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt) from the 
School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, 
Johannesburg (61). 
 
The communities monitored by the Agincourt health and socio-demographic surveillance system 
(HDSS), henceforth referred to as the MRC/Wits-Agincourt Unit, cover about 420km
2
 and are 
situated 500 km northeast of Johannesburg close to the border with Mozambique (Figure 11). 
The population under surveillance in the HDSS as of 1st July 2011 was 90,000 people in 20,000 
households in 27 villages (61). A part of the former Gazankulu homeland, Tsonga is the most 
widely spoken language. A third of the population are Mozambicans who immigrated into South 
Africa mainly as war refugees in the early- and mid-1980s and through the years have 
intermarried with host the South African population with whom they share similar cultures. 
Despite some receiving group refugee status in 1993 and a history of long stay in South Africa, 
the majority of these Mozambicans are still socio-economically disadvantaged (62, 63). 
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Figure 11: Map of Agincourt HDSS 
 
3.1.2 Health service infrastructure and health profile 
The national vision for health system in South Africa is primary health care through a 
decentralised, municipal-based, district health system (DHS). In the late 1990s, the government 
of South Africa began the process of decentralising provision of health services by dividing the 
country into 53 health districts to ensure that citizens have access to a comprehensive package of 
primary health care and district hospital services (64, 65).  In the South African PHC model, the 
nurse is the provider of services in the clinics and comprehensive health centres which are the 
first point of entry to the health system. Located within the reach of rural, semi-rural and urban 
communities, these facilities are the cornerstone of the public health system through provision of 
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comprehensive and integrated ―preventive, promotional, curative and rehabilitation services‖ 
(66).  
 
The range of services provided in PHC clinic include: maternal and child care, immunization, 
family planning, treatment of sexually transmitted infections, minor trauma and care for chronic 
diseases (e.g. diabetes and hypertension). Additional services offered by PHC centres include 24 
hour maternity services, accident and emergency services, up to 30 beds for observation for a 
maximum of 48 hours, and a procedure room (not an operating theatre). With the exception of 
emergency cases which are referred to the hospitals (secondary level of care), the clinics and 
health centres offer services to ambulatory patients for 8 hours/day and 24 hours, respectively 
(66). Medical doctors visit the PHC facilities at intervals to offer support to the nurses (66). In 
the Bushbuckridge municipality, there are 38 PHC facilities and three referral hospitals situated 
25 and 45 km from these PHC facilities (61). 
 
A dual burden of HIV/AIDS and NCDs has been reported in the MRC/Wits-Agincourt Unit 
study site (4). In the 1992-2005 periods, all-cause mortality increased substantially by 87%, 
largely because of a six-fold rise in infectious and parasitic diseases (mainly HIV/AIDS and TB) 
and a modest increase in NCDs. The increase in mortality from infectious and parasitic diseases 
was significant for all age and sex groups except children aged 5-14 years and adults 65 years 
and above. The increase in mortality from NCDs was significant for men but showed little 
change for women (4). In a more recent HIV/cardiometabolic risk factor survey in 2010-2011, 
HIV prevalence was 26% in women and 19% in men and the prevalence of hypertension was 
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high (40% in women; 30% in men) (67). In the MRC/Wits-Agincourt study site, there is 
evidence that women live longer than men (4) probably because they are more aware of their 
conditions, report higher prevalence of factors associated with higher mortality and utilise 
healthcare services (68). The dual burden of HIV and NCDs in the MRC/Wits-Agincourt study 
site is a reflection of the health transition in South Africa (38) which has been addressed through 
the introduction of the ICDM model that was evaluated in this thesis. 
3.1.3 Socio-economic status and social infrastructure 
With Mpumalanga province a having poverty rate of 64%, one of the highest in South Africa 
(69), the study area is characterised by high levels of poverty.  Unemployment levels are 
generally high and estimated at 29% for men and 46% for women (70-72).  Sixty percent (60%) 
of labour migration is accounted for by men aged 35-54 years and an increasing proportion of 
labour migrants is seen among younger men and women (63). This pattern of labour migration 
has resulted in a disproportionately higher proportion of older women permanently residing in 
the area. The main sources of income for the formally employed people, particularly men, are the 
mining sector; security and construction firms; and nearby plantations and game reserves. 
Formally employed women work as domestic workers and on farms. Some families are 
supported by government support grants such as child support grant and old-age pensions (70-
72).    
 
Despite the current government‘s development initiatives which have led to improved housing 
and access to potable water, electricity, and social security grants, social infrastructure in the area 
is still limited. The main methods of sewage disposal range from traditional pit latrines to 
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ventilated improved pit latrines; hence, the poor sanitary conditions in the area. The main means 
of public transport is privately-owned taxis which are limited in number; hence, the high costs of 
transportation (62, 63, 73).  
3.2 Data and methods  
This study has two main components. The first study designed to address the first research 
objective was an analysis of secondary data on healthcare utilisation (HCU) to describe disease 
profiles and predictors of healthcare use in the population monitored by the MRC/Wits-
Agincourt Unit (Table 1). Analysis of the HCU data informed the development of the second 
study which I designed, named ―Vunene Study‖ and implemented for my doctoral research. The 
word ―Vunene‖ means ―goodwill‖ in Tsonga language and is an appropriate name for the second 
study because it reflects the goodwill of the Minister of Health, Dr. Aaron Motsoaledi, in 
introducing the pilot of the ICDM model as a health intervention to tackle the dual high burden 
of HIV and NCDs in South Africa. The Vunene study was a facility-based research project 
consisting of three sub-studies which addressed the second, third and fourth research objectives 
outlined in Table 1. The HCU and Vunene studies contribute to the three broad themes of this 
thesis: chronic disease profile and predictors of healthcare utilisation; quality of care in the 
ICDM model; and changes in patients‘ health outcomes attributable to the ICDM model. The 
next subsections describe the methods (study design; sampling; data collection and quality 
control measures; data management and statistical analysis) underpinning the studies that address 
these themes. 
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3.2.1 Chronic disease profile and predictors of healthcare utilisation 
3.2.1.1 Study design 
This was a cross-sectional analytical survey of 10,249 older adults registered in the 2009 census 
database. This population-based study involved adults aged 50 years and older who responded to 
the healthcare utilisation survey conducted in 2010, the year before the ICDM model was 
introduced.  
3.2.1.2 Sampling 
Of the 10,249 adults registered in the database, 7,870 persons with permanent residency status 
were eligible and targeted for the 2010 HCU survey (Figure 12). Eligibility criteria for the 
interviews were: (i) being 50 years or older; (ii) residency status of 21 days or more before the 
survey for those prospective participants who immigrated in the study site before the 2010 
survey; and (ii) availability of the prospective participants at home after a maximum of two 
revisits by field workers.  
 
Figure 12: Sampling of study participants in the predictors of healthcare utilisation study 
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3.2.1.3 Data collection and quality control 
Field workers were trained for two days in the administration of the HCU questionnaire as part 
of the preparation for the Agincourt Unit census. Field work was closely supervised for a week, 
after which a new training session was run to review and tackle challenges. Data were collected 
by field workers during the census period.  
Quality control followed a four-step system where field workers, supervisors, quality checkers 
and data entry clerks assured good quality of the data. First, field workers double- checked all 
questionnaires before leaving the household of the interviewee and again at the office before 
submission to the supervisors. Secondly, supervisors randomly checked the questionnaires for 
inconsistencies and blank questions before submitting to the quality checkers. The third step 
involved quality checkers identifying inconsistencies and other errors in the questionnaires 
before submitting to the data entry clerks. Finally, data entry clerks identified forms with errors 
during data entry through automated validation checks done in Microsoft SQL server 2005 and 
returned them to the field for correction, after which the whole process of quality control was 
engaged prior to final data was accepted and archived in the final database. 
3.2.1.4 Data management and statistical analysis 
Data management 
The dependent variable was healthcare utilisation (defined as the need for and access to 
healthcare, at least once, less than one year before the HCU survey in 2010) which was a binary 
(Yes vs. No) variable.  Independent variables were age, education, access to medical aid, need 
for healthcare, nationality of origin, socio-economic status, looking for a paid job, receipt of a 
social grant, previous hospitalization, disability, type of illness, and actions taken during illness. 
Age in years was calculated at 1st August 2010 using the census date of birth for all potential 
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participants. Responders were then categorised into 10 year age intervals: 50-59, 60-69 and 70+. 
The cut-off for defining old age was fifty years.  
 
Years of formal education were obtained from the 2007 MRC/Wits Agincourt Research Unit 
census round which was the latest updated education information before 2010. Years of 
education were categorised according to the WHO levels of education: no formal education, less 
than six years and six or more years. Medical aid was categorised to reflect responders with: (i) 
medical aid to visit the doctor (ii) health insurance for specific disease (iii) medical aid in 
employer‘s clinic/hospital (iv) access to free public hospital care and (v) no medical aid/don‘t 
know. The variable ―last time healthcare was needed‖ was categorised into: (i) < 1 year, (ii) 1 - 3 
years, (iii) > 3 years and (iv) never. In order to minimise errors due to recall bias, analysis of the 
predictors of HCU was restricted to responders who reported needing healthcare less than one 
year preceding the survey. The justification for using less than one year as the cut-off was based 
on the assumption that it was easier for responders to recall experiences with HCU in less than 
one year than in 1-3 years or > 3 years. 
 
Nationality of origin was grouped into South Africans and Mozambicans. Socio-economic status 
(SES) was constructed from the household asset score in the 2009 census data. A principal 
component factor analysis technique was used to construct SES based on thirty variables on 
access to water and electricity, type and size of dwelling, appliances, ownership of livestock and 
transport available. Subsequently, responders were categorised into quintiles in the ascending 
order of lowest, middle low, middle, middle high, and highest socio-economic status (71).  
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In order to ascertain employment status, the variable ―looking for a paid job‖ was categorised as 
‗Yes‘ or ‗No‘. Receipt of type of social grant was recorded as none, old age, and disability, 
accordingly. Hospitalisation, HCU (defined as the need for and access to healthcare, at least 
once, less than one year before the HCU survey in 2010) and disability were all binary variables 
(Yes vs. No). Apart from acute conditions (fever and flu) and chronic communicable disease 
(HIV and TB), other types of illness were generated by recoding the reasons for visiting health 
facilities into non-communicable disease (e.g. hypertension, diabetes, stroke, sleep disorder, 
chronic pain in joints, depression, anxiety, cancer, heart problems), injuries and others types of 
illness (musculoskeletal pain and nutritional deficiency). Actions taken during an illness episode 
less than one year before the survey included: visiting public and private health facilities. Other 
actions included practicing self-medication, consulting faith/traditional healers and taking no 
action.  
Statistical analysis  
Data were extracted into Stata 12.0 (College Station, TX, USA) for statistical analysis. Socio-
demographic variables and patterns of healthcare use were described. At p-value of 0.05, 
bivariate analysis compared responders who used healthcare services with those who did not. 
The cut-off point for univariate binary logistic regression analysis was set at p-value of ≤ 0.2 and 
variables that were significantly associated with HCU were used to model the multivariate binary 
logistic regression analysis (p-value ≤ 0.05). Multiple imputation by chained equations (MICE) 
approach for categorical variables was used to impute for ―socio-economic status‖ and ―looking 
for a paid job,‖ which had 1.3% and 12.4% missing values, respectively. Multiple imputation is a 
simulation-based method for analysing incomplete variables. It predicts missing values as close 
as possible to the true ones by replacing missing data with probable values based on other 
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available information (74). Imputation is considered to have less estimation bias and valid 
statistical inference than list-wise deletion because the latter leads to loss of statistical power 
(75).  
3.2.2 Quality of care in the ICDM model 
A quantitative study and a qualitative study were used to evaluate the quality of care in the 
ICDM model. A combination of methodological and data triangulation was used to enhance 
validity of the data on quality of care in the ICDM pilot facilities. Methodological triangulation 
involved the use of quantitative and qualitative methods to gather data while data triangulation 
was achieved through data collection from different population subsets at different times and 
spaces.  
3.2.2.1 Study design of the quantitative quality of care study 
The quantitative sub-study was a cross-sectional primary survey of patients 18 years and above 
receiving treatment in the ICDM pilot PHC facilities between August and November 2013. 
Considering the burden of chronic diseases in the study area, patients with markers of chronic 
diseases for HIV, hypertension, and diabetes in the health facilities were included in the study, 
while those with other chronic diseases were excluded. Other study participants were the seven 
operational managers (professional nurses-in-charge) of the ICDM pilot facilities. The dataset 
was used to assess patients‘ and operational managers‘ satisfaction with the dimensions of ICDM 
services and evaluate the quality of care in the ICDM model using Avedis Donabedian‘s theory 
of relationships between structure, process, and outcome constructs.  
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Sub-sections 3.2.2.2 and 3.2.2.3 show how the ICDM pilot facilities and patients receiving 
treatment in these facilities were sampled, respectively. Sub-section 3.2.2.4 describes the study 
instrument used for the data collection and sub-section 3.2.2.5 shows how data were collected 
from the selected patients. 
3.2.2.2 Sampling of ICDM pilot facilities in the quantitative quality of care study 
The ICDM model was implemented in 17 of the 38 PHC facilities in the municipality at the time 
the study on quality of care was conducted. From these, the seven health facilities serving the 
communities in the Agincourt sub-district monitored by the MRC/Wits-Agincourt Unit were 
purposively selected into the ICDM pilot arm of the study.  
3.2.2.3 Sampling of patients in the quantitative quality of care study 
Inclusion criterion was patients who had hypertension, diabetes and HIV managed for at least 
five months before the initiation of the ICDM model until the time the study commenced in 
August 2013. The reason for including patients receiving treatment five months before the ICDM 
model was implemented was to assess the levels of satisfaction of patients who had received 
treatment before the implementation of the ICDM model and continued to receive treatment 
during its implementation in efforts to gauge possible changes in the quality of care for 
hypertension, diabetes and HIV attributable to the ICDM model. Patients diagnosed with other 
chronic diseases and minors less than 18 years were excluded from the study because they were 
considered to be below the age of autonomy for judging satisfaction with the quality of care for 
hypertension, diabetes and HIV provided in the health facilities. Elderly patients with reduced 
capacity for comprehension during informed consent were also excluded from the study. 
Diminished capacity for comprehension was determined by the inability of prospective patients 
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to comprehend or respond to the information verbally provided by the interviewer during 
informed consent.  
 
Using the subjects-to-variables ratio (minimum of 10 subjects per variable in the study 
instrument) for estimating sample size for studies utilising factor analysis (76, 77),  a sample size 
of 390 patient respondents was calculated (17 subjects per each of the 23 variables in the study 
instrument). The minimum sample size of approximately 435 patients was reached after 
adjusting for 10% (390/0.9) non-response. All the seven operational managers of the PHC 
facilities, the maximum number possible, were selected because they offered clinical services to 
the patients and the authors perceived their role as managers of the health facilities more 
important than the professional nurses in understanding the quality of the ICDM model. 
 
Patients were identified through a multi-stage sampling technique using the facility rosters in 
July 2013, the month before the study was commenced (Figure 13). First, the number of patients 
recruited in each of the seven health facilities was determined by proportionate sampling. 
Secondly, the patients in each health facility were proportionately sampled by HIV, 
hypertension, and diabetes status in order to get a representative sample of the patients with 
markers of chronic diseases using a health facility-specific sampling frame. Finally, the numbers 
of patients specified in step two were recruited for a daily interview until the desired sample size 
in each clinic was achieved (See appendix 2a for details on the sampling technique).  
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Figure 13: Sampling of study participants in the quality of care in the ICDM model study 
 
3.2.2.4 Study instrument used to evaluate quality of care  
Some study instruments have been recommended and were considered for assessing patient 
satisfaction with healthcare. The Patient Satisfaction with Nursing Care Quality Questionnaire 
(PSNCQQ) was designed by Laschinger et al. in 2005 (78). It has 19 items with three additional 
questions designed to measure the validity and enable assessment of overall satisfaction with the 
quality of care and treatment during the hospital stay, overall quality of nursing care, and 
intentions to recommend the hospital to family and friends. All items in the PSNCQQ focus on 
process-related care offered by nurses, while none of the items explored structure-related (e.g. 
availability of equipment) or outcome-related (e.g. patient waiting time) aspects.  
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The multi-scale patient satisfaction questionnaire (PSQ-18) was developed by Ware et al. (79). 
The PSQ-18 comprises 18 items derived from the full-length version (50-item) PSQ-III 
counterpart (79). The PSQ-18 assesses multiple dimensions of patient satisfaction and includes 
general satisfaction, technical quality, interpersonal relations, communication, financial aspect, 
time spent with health provider, and accessibility and convenience (Appendix 1). The PSQ-18 
sub-scales show acceptable reliability and correlate with the sub-scales in the PSQ-III (80). 
Furthermore, PSQ-18 is appropriate for use in situations where there is need for brevity (80) as 
was the case in this study where it was administered to patients leaving the health facility after 
consultations with the nurses (patient exit interviews). 
 
The PSQ-18 instrument was selected because the PSNCQQ is not reflective of Donabedian‘s 
SPO constructs. Furthermore, the PSQ-18 succinctly measures satisfaction with dimensions of 
care for which SPO constructs are intended. I am not aware of any study that has used the PSQ-
18 as a study instrument to operationalise Avedis Donabedian‘s SPO theoretical framework in 
SSA. 
 
The quantitative quality of care study compared self-reported satisfaction of the patients and self-
reported satisfaction of the operational managers with the dimensions of care listed in the ICDM 
model using the multi-scale PSQ-18. This is in view of literature depicting views of health care 
providers differing from users regarding the quality of health care (81). Responses to statements 
were scored on a five-point Likert scale ranging from 4 (strongly agree) to 0 (strongly disagree) 
for positively-phrased statements, and from 4 (strongly disagree) to 0 (strongly agree) for 
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negatively-phrased statements for the purpose of undertaking confirmatory factor analysis and 
structural equation modeling.  
 
Similar to another study in which the PSQ tool was adapted to measure patient satisfaction with 
pharmacy services (82), this study adapted the PSQ-18 by altering a number of statements to fit 
the ICDM model.  For example, the structure-related statement, ―I have easy access to the 
medical specialists I need,‖ was changed to the ICDM-process-related dimension, ―Health care 
providers usually refer me to the doctor/hospital when there is need for the doctor to review me - 
P5‖ (Appencices 1, 3 and 4). One structure-related (supply of critical medicines) and two 
process-related (defaulter tracing of patients and prepacking of medicines) variables were 
included in the adapted questionnaire. One process-related statement in the PSQ-18 was changed 
from ―health care providers act too business-like and impersonal toward me‖ to ―Health care 
providers are professional in the conduct of their clinical duties‖. Two outcome statements on 
―satisfaction with perfect health care‖ and ―dissatisfaction with some care‖ in the PSQ-18 were 
changed to the dimension on ―satisfaction with coherent integrated chronic disease care‖ and 
―dissatisfaction with coherent integrated chronic disease care‖, respectively. Regarding the 
types of outcome constructs (technical and interpersonal) specified by Donabedian, the focus of 
this quantitative study on quality of care was on the subjective interpersonal outcome. 
 
Two statements around the financial costs of health care (D1 and D2) were dropped during the 
adaptation of the PSQ-18 (Appencices 1, 3 and 4). This is because the government of the 
Republic of South Africa implements a pro-equity policy, a component of free health care for 
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everyone using the public primary health system (83). However, transport-related costs were not 
considered in this study because it is not the responsibility of South Africa‘ Department of 
Health to provide transport for the implementation of the ICDM model. The 17 dimensions of 
care in the adapted questionnaire are shown in Figure 14, and details of the adapted PSQ tool 
used in the current study for patients and operational managers are shown in Appendices 3 and 4, 
respectively.  
 
Figure 14: The dimensions of care in the ICDM model for which the structure, process and 
outcome constructs were intended.  
 
The dimensions in red colour indicate the priority areas of HIV programme leveraged for chronic 
diseae care in the ICDM model. 
 
Eight dimensions of care were identified by experts on quality of care in the study team as 
priority areas for enhancing service efficiency and quality of care: supply of critical medicines, 
hospital referral, defaulter tracing, prepacking of medicines, clinic appointments, patient waiting 
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time, and coherence of integrated chronic disease care (20). This is because these priority areas 
are components of the tools and systems used in the successful HIV programme which is being 
leveraged to support or scale-up services for improving the quality of care for NCDs (Figure 13). 
 
3.2.2.5 Data collection and quality control in the quantitative quality of care study 
Having consulted with the professional nurses and received their medicines, the prospective 
study participants were invited to a (consultation) room designated for patient interviews. Only 
the interviewer had access to this consultation room. Patients were invited to take part in the 
satisfaction survey after explaining the purpose of the study. They were assured that there will be 
no penalty or loss of benefits to which they were entitled to if they chose to not participate in this 
study or decide to discontinue participation in this study. Written informed consent was obtained 
from the patients who were willing to participate in the study and interviews were conducted 
with the patients. Refusal was less than 1%.  
 
The adapted PSQ tool was forward translated to Tsonga (the local language) and back-translated 
to English by two experienced field workers who were blinded to each other. An experienced 
quantitative field worker was trained on how to administer the adapted PSQ tool. A pilot study 
was conducted in Cork clinic, a PHC facility situated outside the study site, to assure 
understanding and correct use of the PSQ tool. Only a few statements had to be rephrased after 
the pilot study. An important characteristic of the original PSQ-18, which was considered in the 
adaptation of the study instrument, is the control for Acquiescent Response Set (ARS) - a 
tendency to agree with statements of opinion regardless of their content (84). Six variables were 
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phrased in opposite directions, bringing the total number of variables in the adapted 
questionnaire to 23 (Appendices 3 and 4). These measures are beneficial in detecting skewness 
toward satisfaction (84) and identifying specific programme areas in which  respondents are 
satisfied or dissatisfied.   
3.2.2.6 Data management and statistical analysis in the quantitative study 
Data management and the operationalisation of Donabedian’s theoretical framework  
A priori identification of 17 dimensions of care for which the SPO constructs were intended was 
undertaken to reflect Donabedian‘s theory of the relationships between these constructs (Figure 
13). Of the 17 dimensions of care assessed in this study, 10 were adapted from the Patient 
Satisfaction Questionnaire (PSQ-18) (79) used as study tool in the exit interviews. The remaining 
eight dimensions of care were identified by the study team as priority areas for improving quality 
of care in the ICDM model: supply of critical medicines, hospital referral, defaulter tracing, 
prepacking of medicines, clinic appointments, reducing patient waiting time, and coherence of 
integrated chronic disease (20). These priority areas are the tools and systems in the HIV 
programme used for leveraging services for NCDs.  
 
The adapted PSQ also contained measures reflective of three of the six priority areas of the 
National Core Quality Standards. There was no clear division of the statements in the adapted 
study instrument into SPO constructs under which the dimensions of care have been categorised. 
However, these statements have been categorised under these constructs in Appendices 3 and 4 
for clarity and ease of comprehension. In order to minimise bias that may result from assessing 
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the acquiescent response set, the positive and negative statements did not follow each other in the 
questionnaire as shown in Appendices 3 and 4.  
 
Responses to statements were scored on a five-point Likert scale ranging from 4 (strongly agree) 
to 0 (strongly disagree) for positively-phrased statements, and from 4 (strongly disagree) to 0 
(strongly agree) for negatively-phrased statements. Satisfaction scores of the patients were used 
for conducting confirmatory factor analysis and structural equation modeling (SEM). The 
respondents were judged to be satisfied with the dimensions of care if the total relative frequency 
was ≥ 50% for ―strongly agree‖ and ―agree‖ responses to positively-phrased statements. 
Similarly, the respondents were judged to be satisfied with the dimensions of quality of care if 
the total relative frequency was ≥ 50% for ―strongly disagree‖ and ―disagree‖ responses to 
negatively-phrased statements. A satisfaction score of at least 50% was considered an average 
score using a scale of 0% to 100%. 
 
The patients (P) and operational managers (OM) were scored comparatively on their 
(dis)satisfaction with the dimensions of care in the ICDM model. The quality of care in the 
ICDM model was measured by conducting structural equation modelling (SEM) using the data 
on patients‘ (dis)satisfaction with the dimensions of care in the ICDM model. However, SEM 
could not be performed with the data collected from the operational managers because of the 
very small sample size (seven operational managers). 
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The following linear pathways were specified in the SEM (Figure 15): (1) the unidirectional 
pathway which states that good structure promotes good process and good process in turn 
promotes good outcome; (2) the mediation pathway which posits that good structure directly 
promotes good outcome; good structure promotes good process and good process in turn 
promotes good outcome; and (3) the reciprocal pathway which hypothesises that good structure 
promotes good process, good process promotes good outcome and good outcome promotes good 
process.  The last two pathways were examined in this study to explore other linear relationships 
between SPO constructs other than the unidirectional pathway originally postulated by 
Donabedian (Figure 15). 
 
Figure 15: The path models for operationalising Donabedian‘s theory in the ICDM model of care 
in South Africa 
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Fitting of the proposed pathways involved a four-step systematic process using patient data. 
First, a priori identification of the variables for which the SPO constructs were intended was 
performed by the experts on quality of care on the study team in order to assess the validity of 
the adapted questionnaire (Appendices 3 and 4). This method was adopted by Kunkel et al. in 
which a panel of experts categorised variables in a questionnaire into SPO constructs (60). 
 
Secondly, Cronbach‘s alpha (range: 0-1) which is a measure of internal consistency was used to 
quantify the reliability of the multi-item variables in the adapted PSQ in measuring the SPO 
constructs. Cronbach‘s alpha coefficient of reliability was categorised as excellent (α ≥ 0.9), 
good (0.7 ≤ α < 0.9), acceptable (0.6 ≤ α < 0.7), poor (0.5 ≤ α < 0.6) and unacceptable (α < 0.5) 
(85).  
 
Next, the negative statements in the pair of statements phrased in opposite directions were 
dropped if there was no evidence of ARS.  The fit of each construct and its individual items were 
assessed to remove any of the remaining variables with low coefficient of determination (CD < 
0.2). Variables with low CD contribute high levels of error in the structural equation modelling 
(86). Thereafter, Confirmatory Factor Analysis (CFA) was conducted to identify and remove the 
variables that did not load significantly (factor loading < 0.300) onto their intended constructs. 
 
The following step used structural equation modelling (SEM) to assess the specific pathways, as 
used elsewhere (87) in order to determine the relationships between the SPO constructs in Figure 
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14. Selection of the final path model was based on the variables that reflected their intended 
factors (factor loading ≥ 0.300). The Maximum Likelihood for Missing Values (MLMV) 
technique was used to impute for S5, P1 and P11 variables with 0.5%, 0.25% and 0.25% missing 
observations, respectively. The MLMV is a technique that handles missing data by estimating a 
set of parameters that maximise the probability of getting the data that was observed. It is a more 
superior and preferable method for handling missing data than the more popular multiple 
imputation (88), which is a simulation-based method that predicts missing values as close as 
possible to the true ones by replacing missing data with probable values based on other available 
information (74).   
 
Assessment of the fit of the pathways using MLMV approach was based on two or more of the 
fit indices described in this paragraph (89): Chi-squared (χ2) test is an absolute fit index that  
assesses the discrepancy between observed and expected covariance matrices -  χ2 p-value > 0.05 
is a good fit.  However, χ2 test may not be a reliable fit index because it is almost always 
statistically significant for models with sample size ≥ 400 (86); Root Mean Squared Error of 
Approximation (RMSEA) is another absolute fit index that measures how well a model with 
optimally chosen parameter estimates fit the population‘s covariance matrix - RMSEA value ≤ 
0.06 is a good fit; Comparative Fit Index (CFI) is an incremental fit index that assesses the 
improvement in fit of the hypothesised model compared with a baseline (null) model, when 
population covariance is assumed to be zero - (CFI ≥ 0.90 is a good fit); Tucker-Lewis Index 
(TLI) is also an incremental fit index that corrects for model complexity by favouring 
parsimonious models over more complex ones - (TLI ≥ 0.90 is a good fit); and (v) Coefficient of 
determination (CD) indicates how well data fit a statistical model. We used CD to decide the 
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model that explained the most variability. CD value of 1.00 is a perfect fit. The higher the 
number of criteria used, the better the fit of the model with the data (86). 
Statistical analysis 
Data were entered into Access 2010 and imported into Stata 12.0 (College Station, TX, USA) for 
statistical analysis. Relative frequencies were used to quantify socio-demographic variables, 
chronic disease status of patients and satisfaction of the patient and operational managers with 
the dimensions of integrated chronic disease services. At p-value ≤ 0.05, CFA and SEM were 
used to fit the specified structural path models in order to determine the quality of care in the 
ICDM model from the patients‘ perspective. 
3.2.2.7 Study design of the qualitative component of the quality of care study 
The qualitative component of the quality of care study was a case study of the ICDM pilot 
facilities which also used Donabedian‘s theoretical framework to assess quality of care in the 
ICDM model based on healthcare user and provider perspectives.  
3.2.2.8 Sampling of participants in the qualitative study 
Of the 435 patients who responded to the quantitative exit interviews in the ICDM pilot facilities, 
70 were purposively selected for seven focus group discussions ((FGDs) i.e. 10 patients per 
FGD) and 10 were purposively selected for one FGD for clinic defaulters with at least one 
patient selected from each of the seven clinics). Focus Group Discussions (FGDs) were 
conducted to obtain in-depth data from multiple patients to capitalise on group interactions and 
communication regarding lived experiences based on provider-user interface. Of the 70 selected 
patients, 56 participated in the FGDs and five of the 10 selected patients participated in the FGD 
for clinic defaulters. The Exit interviews preceded the FGDs to make it easy to access patients 
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and to provide a large sampling frame from which prospective participants in the FGDs were to 
be purposively selected. Patients for the FGDs were selected from all clinics during official 
working hours (8.00am - 4.30 pm local time) from Monday to Friday. The FGDs were held on 
Saturdays at a time that was convenient for most of the patients.  
 
 
 
 Figure 16: Sampling of patients for the focus group discussions 
 
In-depth interviews were held for the seven operational managers of the health facilities and the 
health manager of the Bushbuckridge municipality to get the depth and breadth of provider 
perspective on the quality of care in the ICDM model. A range of 6-10 patients was targeted for 
FGDs in each health facility. After the exit interviews, patients were briefed about the purpose 
and scheduled dates of the upcoming FGDs. Those who volunteered to participate in the FGDs 
were invited to do so based on the following: i) having commenced treatment for the markers of 
chronic conditions in the study area (HIV, hypertension and diabetes) six months before the 
implementation of the ICDM model; ii) having participated in the exit quantitative interviews 
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organised by the research team before the FGDs; iii) and willingness to participate in the study 
irrespective of nationality. The exit interviews were used as a means of identifying patients who 
overwhelmingly reported satisfaction or dissatisfaction with the quality of care in the priority 
areas of the ICDM model and purposively selecting these patients for FGDs to further explore 
their in-depth perspectives on the quality of care in the ICDM model. The operational managers 
were selected for in-depth interviews because of their roles and responsibilities which were 
previously described.  The municipality health manager was interviewed in order to understand 
the policy environment for the operational implementation of the ICDM model. The FGDs and 
in-depth interviews were held in parallel. 
3.2.2.9 Data collection and quality control in the qualitative study 
The 17 dimensions of care in the adapted PSQ were used as the thematic areas in the qualitative 
component of the quality of care study. A total of eight FGDs were conducted. The FGDs were 
held in a centrally-located neutral venue within the catchment area of the health facility to enable 
the patients to freely express and communicate their lived experiences with healthcare services. 
Seven FGDs were held for 5-9 patients of similar age and mixed gender recruited from within 
the seven PHC facilities, with each session lasting 60-90 minutes; and one FGD was held for five 
clinic defaulters (those who missed three consecutive clinic appointments as was observed 
through the review of clinic records) from within the seven health facilities. The purpose of 
selecting participants of similar age was to provide a conducive environment for the participants 
to freely discuss their experiences with the health system without fear or intimidation. Moreover, 
eight interviews lasting 30-40 minutes were conducted with the seven operational managers and 
the municipality health manager. I administered the respective topic guides for the in-depth 
interviews to the operational managers and the municipality health manager.  
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I ran a two-day training session with two female experienced qualitative field workers, with at 
least ten years of field experience in the Agincourt HDSS. During the training, I briefed the field 
workers about the purpose of the study and on how to administer the topic guide to the patients. 
One field worker audiotaped and moderated the discussions while the other took notes during the 
FGDs which were held in Tsonga. In order to assure quality of the data, the FGD audio 
recordings were translated and transcribed into English by these qualitative field workers. A third 
qualitative field worker in the Agincourt HDSS validated the transcriptions by listening to two of 
the seven audiotapes and also translated them into English. A comparison of the earlier and latter 
transcriptions showed no major differences in the participants‘ experiences and opinions 
regarding the dimensions of quality of care in the ICDM model. Similar procedures were used to 
assure data quality for the in-depth interviews.  
3.2.2.10 Data processing and analysis of the qualitative study 
The transcribed FGDs and interviews were thematically analysed using MAXQDA 2 software. A 
combined deductive and inductive approach was used for data analysis. The deductive analysis 
was based on the pre-identified themes focusing on the in-depth inquiry of the dimensions of 
care in the ICDM model. Inductive analysis was undertaken for an emerging theme that was not 
anticipated at the outset and not included among the 17 dimensions of care covered in the topic 
guide. I coded the data while a qualitative researcher verified the coded data through the reading 
and rereading of the quotes. A codebook was developed based on recurring pre-identified themes 
and emerging themes. Reliability of the coded data was verified through discussion of 
inconsistent codes with a qualitative researcher and supervisors until agreement was reached. 
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3.2.3 Changes in patients’ health outcomes attributable to the ICDM model 
Five facilities outside the Agincourt HDSS were randomly selected into the comparison arm 
from the 21 PHC facilities in the Bushbuckridge municipality where the ICDM model was not 
implemented. Hence, this sub-study had the ICDM pilot and comparison study arms to enable a 
comparative assessment of patients‘ health outcomes attributable to the ICDM model. Unlike the 
quantitative sub-study on quality of care in the ICDM model which focussed on the subjective 
interpersonal assessment of outcomes specified by Avedis Donabedian, the focus of this sub-
study was on the objective technical assessment of patients‘ health outcomes (e.g. CD4 counts 
and BP) (58) . 
3.2.3.1 Study design 
This was an interrupted time-series analysis of data retrieved from facility records in the ICDM 
pilot and comparison facilities to determine the effectiveness of the ICDM model in improving 
patients‘ health outcomes. The defining feature of ITS design is that each participant in the 
sample is observed multiple times before and after an intervention (90). The ITS study design is 
the strongest quasi-experimental design to evaluate longitudinal effects of a non-experimental 
intervention implemented by someone other than the evaluation researcher (90), as was the case 
in this study. 
3.2.3.2 Sampling of patients 
A minimum sample size of 435 patients in each study arm after adjusting for a 10% non-
response using Diggle‘s sample size formula for repeated measures in which a continuous 
outcome variable is consistently compared between two groups across 30 time points (months) 
of observation in a longitudinal study (91),  assuming an effect size of 0.22; 0.90 correlations of 
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repeated outcomes; 90% power (Zβ=1.28); and 5% significance level for a two-sided hypothesis 
test (Zα/2=1.96).  
 
Overall, 435 patients were recruited in the ICDM pilot and 443 patients in the comparison 
facilities (Figure 17). The multi-stage proportionate sampling previously described in the 
quantitative sub-study on quality of care was applied in the recruitment of the 443 patients in the 
comparison facilities (See appendix 2b for details on the sampling technique).  
 
Figure 17: Sampling of study participants in the patients‘ health outcomes study 
 
3.2.3.3 Data collection and quality control   
A retrospective records‘ review of health outcomes (e.g. viral load, CD4 count and blood 
pressure) of 435 patients in the pilot facilities and 433 patients in the comparison facilities was 
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performed in the January 2011 to June 2013 periods. The unique identifiers of these patients 
were anonymised and study numbers generated.  
3.2.3.4 Data management and statistical analysis 
At the time of the study, eligibility criteria for ART initiation were CD4 count ≤ 350 cells/mm3; 
WHO clinical stage 3 or 4; and pregnancy or breastfeeding status (92). For those on ART, viral 
load was repeated every 12 months and CD4 count repeated six monthly for ART monitoring 
purposes with the expectation that CD4 count would be > 350 cells/mm
3
; henceforth, referred to 
as ―controlled CD4 count‖ in this thesis. Appendix 5 shows the treatment regimens 
recommended for HIV/AIDS patients in South Africa throughout the duration of the study (92). 
At every visit, adherence to ART was assessed by pill-count and record of clinic attendance. A 
pill count of more than 95% of ART doses was considered good adherence (92). Unstable 
patients were reviewed monthly until stability was achieved while stable patients were reviewed 
every two to three months. All patients were routinely referred to the doctor for review every six 
months. 
 
Hypertension is defined as currently taking antihypertensive drugs; or systolic blood pressure ≥ 
140 mmHg or diastolic blood pressure ≥ 90 on three separate measurements two to three days 
apart (92). Controlled hypertension in this thesis refers to BP <140/90 mmHg. Antihypertensive 
drugs used in the study setting are shown in Appendix 5. 
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The main hypothesis was that the ICDM model leads to changes in the CD4 counts and blood 
pressure of patients receiving care in the PHC facilities implementing the ICDM model with an 
allowance of a minimum of eight time points before and after initiation of the model (93) 
Statistical analyses 
Data were entered into Access 2010 and imported into Stata 12.0 (College Station, TX, USA) for 
statistical analyses. Controlled segmented regression analysis, a statistical method for estimating 
the effects of longitudinal intervention in interrupted time series data, was used for modelling the 
data (90, 93). Two time periods were specified: (1) pre-intervention (January-June 2011) - six 
months before initiation of the ICDM model, including the month of June 2011 when the model 
was initiated; and (2) post-intervention (July 2011-June 2013) - 24 months of implementation of 
the model. Two segmented analytical approaches were done: first, the autoregressive moving 
average (ARMA) time series model, and secondly, segmented linear regression to determine the 
effect of the ICDM model over the two specified time periods. The probability of having 
controlled CD4 counts or blood pressure was derived from the person-level analysis using mixed 
effects models which adjusted for the clinics (cluster) in which patients received healthcare and 
other covariates such as age. As a way of smoothing the observed percentages on outcomes, 
propensity scores were derived after the mixed effect regression analysis to show the probability 
of controlling for the outcome of interest in the patients. After collapsing and aggregating these 
health outcomes using the mean percentages of the monthly time points and associated standard 
deviations, the smoothed percentages of the datasets used in the segmented analysis was created.   
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The first segmented analysis was based on the ARMA model in which the data for the ICDM 
pilot and comparison facilities were aggregated and the second segmented analysis was based on 
linear regression on the two time periods.  The main effects as well as the interactions of period 
and intervention/control were modelled across the whole time span to assess the effect of the 
intervention. The goodness of fit of the model was assessed by testing the residuals for normality 
in addition to the visual assessment of the fitted versus observed time series plots.  
 
Propensity score matching (psmatch2) was done to balance the effect of covariates which varied 
in distribution between the study groups (e.g. age) (94). The ordinary least squares regression 
line was fit to each segment of the independent variable (time) assuming a linear relationship 
with the outcome variables within each segment. The regression model was specified to estimate 
the changes in the level (intercept) and trend (slope) for the patients whose BP and CD4 counts 
were controlled at the two time periods (segments) in both study groups (90). The absolute 
difference in the slopes between the segments was calculated by subtracting the original value 
from the final value. The inverse of the standard deviations were used in the segmented analysis 
models as the analytic (importance) weights. The p-values and the 95% confidence interval of 
the parameters were reported to ascertain statistical significance (p-value<0.05).  
3.3 Summary of study designs, nature of outcome variables, data source 
and type of analysis according to thesis themes 
The study designs, data sources and analytical approaches used to assess the three thematic areas 
on chronic disease profile and predictors of healthcare utilisation (I); quality of care in the ICDM 
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model (II); and changes in patients‘ health outcomes attributable to the ICDM model (III) are 
shown in Table 2 below. 
Table 2: Summary of study designs, type of outcome variables, data sources and type of analysis 
according to the three thematic areas in this thesis 
Theme Study design  Type of variables  Data 
source 
Type of 
analysis 
I Cross-sectional 
analytical 
Binary Agincourt 
2010 HCU 
module 
(secondary 
data) 
Univariate and 
multivariate 
binary logistic 
regression 
modeling 
II 
 
Cross-sectional 
analytical 
 
 
Case study of 
healthcare facilities 
Ordinal (Likert scale 
from strongly agree to 
strongly disagree) 
 
 
- 
Primary 
data 
 
 
 
Primary 
data 
Structural 
equation 
modeling 
 
 
Thematic 
content 
analysis 
III Interrupted time-
series study  
Continuous Data 
retrieved 
from 
patients‘ 
facility 
records 
Segmented 
linear 
regression 
*For only HIV/AIDS patients 
 
3.4 Ethical considerations 
The three key ethical principles of autonomy, beneficence and justice were upheld by ensuring 
that: patients‘ information were encrypted in a computer programme that keeps the information 
in a form that does not allow anyone to interpret it, except the study team, and that ptients‘ 
unique identifiers are not reported in scientific journals; participants who prefer not to participate 
in the study or decide to discontinue participation in the study are free to do so; there will be no 
penalty or loss of benefits to which participants are otherwise entitled; there is no risk of harm or 
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injury for participating in the study; and there are no direct benefits to participants during the 
study. Ethical approval for the conduct of the research was granted by the Committee for 
Research on Human Subjects (Medical) of the University of the Witwatersrand, Johannesburg, 
South Africa (Ref No. M120943) and the Mpumalanga Provincial Research and Ethics 
Committee. The research that generated the data for the secondary analysis received ethical 
clearance from the Committee for Research on Human Subjects (Medical) of the University of 
the Witwatersrand, Johannesburg, South Africa (Ref No. M960720).  
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4.0 Results 
The results of the two main studies with their component sub-studies have been integrated to 
reflect the three themes of this thesis. These themes are preceded by the patients‘ socio-
demographic characteristics. The themes are (i) chronic disease profile and predictors of 
healthcare utilisation (subsection 4.1); (ii) quality of care in the ICDM model (subsection 4.2); 
and (iii) changes in patients‘ health outcomes attributable to the ICDM model (subsection 4.3). 
Table 14 presents the summary of the results of the three thesis themes by the four papers as 
outlined earlier in Table 1.  
4.1 Chronic disease profile and predictors of healthcare utilisation 
4.1.1 General characteristics of study participants 
The general characteristics of the 5,795 study participants in the healthcare utilisation study 
(Figure 11) are described in this subsection.  
4.1.2 Comparison of responders with non-responders by socio-demographic 
characteristics 
Response rate, defined as the number of respondents divided by the number of eligible subjects 
in the sample (95), was 75% [5,795/(7,870-145)]. A comparison of 5,795 responders and 2,075 
non-responders showed that the responders were older (mean age = 66 vs. 64 years, p<0.001) 
and predominantly women (74.8% vs. 55.4%, p<0.001), whereas non-responders had more of 
formal education (19.1% vs. 12.9%, p<0.001) and highest asset score (25.9% vs. 22.5%, 
p<0.001) – (See Table 3).  
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Table 3:  Socio-demographic characteristics of responders and non-responders to the 2010 
healthcare utilisation survey in the Agincourt sub-district 
VARIABLES Responders 
(n=5,795) 
Non-responders 
(n=2,075) 
Total 
(n=7,870) 
p-value
†
  
Age group (years) 
   50 – 59 
   60 – 69  
   ≥ 70 
 
1,933 (33.3) 
1,703 (29.4) 
2,158 (37.3) 
 
920 (44.4) 
515 (24.8) 
640 (30.8) 
 
2,853 (36.2) 
2,218 (28.2) 
2,799 (35.6) 
 
<0.001 
Mean age in years  66.1 (65.8 , 66.4) 64.0 (63.5 , 64.5) 65.6 (65.3 , 65.8)  
Gender 
    Female 
    Male 
 
4,333 (74.8) 
1,462 (25.2) 
 
1,149 (55.4) 
926 (44.6) 
 
5,482 (69.7) 
2,388 (30.3) 
 
<0.001 
Education (in completed years) 
   No formal education 
   ≤ 6 
   > 6 
 
3,680 (63.5) 
1,369 (23.6) 
746 (12.9) 
 
1,263 (60.9) 
415 (20.0) 
397 (19.1) 
 
4,943 (62.8) 
1,784 (22.7) 
1,143 (14.5) 
 
<0.001 
Nationality of origin 
      South Africa 
      Mozambique 
 
4,032 (69.6) 
1,763 (30.4) 
 
1,396 (67.3) 
679 (32.7) 
 
5,428 (69.0) 
2,442 (31.0) 
 
0.052 
Socio-economic status 
    Lowest 
    Middle low 
    Middle 
    Middle high 
    Highest 
    Missing 
 
927 (16.0) 
1,160 (20.0) 
1,239 (21.4) 
1,091 (18.8) 
1,301 (22.5) 
77 (1.3) 
 
339 (16.4) 
391 (18.8) 
359 (17.3) 
421 (20.3) 
538 (25.9) 
27 (1.3) 
 
1,266 (16.1) 
1,551 (19.7) 
1,598 (20.3) 
1,512 (19.2) 
1,839 (23.4) 
104 (1.3) 
 
 
<0.001 
Medical aid cover  
      Free public hospital care 
      Whenever I need to see the doctor 
      Health insurance for specific disease 
      Employer‘s clinic/hospital 
      No medical aid/don‘t know 
 
5,422 (93.6) 
118 (2.1) 
7 (0.1) 
188 (3.2) 
60 (1.0) 
 
- 
- 
- 
- 
- 
 
 
 
 
Occupation  
    Not working for cash payment 
    Working for cash payment 
 
5,016 (86.6) 
779 (13.4) 
 
- 
- 
  
Looking for a paid job  
     Yes 
     No 
     Missing 
 
508 (8.8) 
4,567 (78.8) 
720 (12.4) 
 
- 
- 
- 
  
Type of grant  
     Old age 
     Disability 
     None 
 
3,437 (59.3) 
182 (3.1) 
2,176 (35.6) 
 
- 
- 
- 
 
 
 
†
Chi square test p-value of difference between responders and non-responders 
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4.1.3 Socio-demographic characteristics of adults who used public and private 
healthcare facilities 
Table 4: Socio-demographic characteristics and type of healthcare facility used in the Agincourt 
sub-district in 2010 
Variables Type of healthcare facility n (%) p-value
†
  
Public 
(n=4,089) 
Private   
(n=363) 
Total 
(n=4,452) 
Age (years) 
   50 – 59 
   60 – 69 
   ≥ 70 
 
1,365 (33.4) 
1,186 (29.0) 
1,538 (37.6) 
 
140 (38.6) 
104 (28.6) 
119 (32.8) 
 
1,505 (33.8) 
1,290 (29.0) 
1,657 (37.2) 
 
0.093 
Gender 
   Female 
   Male 
 
3,186 (77.9) 
903 (22.1) 
 
243 (66.9) 
120 (33.1) 
 
3,429 (77.0) 
1,023 (23.0) 
 
<0.001 
Education (completed years) 
   No formal education 
   ≤ 6 
   > 6 
 
2,613 (63.9) 
979 (23.9) 
497 (12.2) 
 
201 (55.4) 
73 (20.1) 
89 (24.5) 
 
2,814 (63.2) 
1,052 (23.6) 
586 (13.2) 
 
<0.001 
Nationality of origin 
      South Africa 
      Mozambique 
 
2,868 (70.1) 
1,221 (29.9) 
 
274 (75.5) 
 89 (24.5) 
 
3,142 (70.6) 
1,310 (29.4) 
 
 
0.032 
Medical aid cover  
      Free public hospital care 
      Whenever I need to see the doctor 
      Health insurance for specific disease 
      Employer‘s clinic/hospital 
      No medical aid/don‘t know 
 
3,878 (94.8) 
25 (0.6) 
2 (0.1) 
168 (4.1)   
4 (0.1) 
 
283 (77.9) 
73 (20.1) 
1 (0.3) 
4 (1.1) 
1 (0.3) 
 
4,161 (93.5) 
98 (2.2) 
3 (0.1) 
172 (3.8) 
5 (0.1) 
 
<0.001 
Occupation 
     Working for cash payment 
     Not working for cash payment 
 
493 (12.1) 
3,596 (87.9) 
 
74 (20.4) 
289 (79.6) 
 
567 (12.7) 
3,885 (87.3) 
 
 
<0.001 
Socioeconomic status 
    Lowest 
    Middle low 
    Middle 
    Middle high 
    Highest 
    Missing 
 
654 (16.0) 
837 (20.5) 
904 (22.1) 
768 (18.8) 
870 (21.2) 
56 (1.4) 
 
36 (9.9) 
58 (16.0) 
66 (18.2) 
66 (18.2) 
137 (37.7) 
0 (0.0) 
 
690 (15.5) 
895 (20.1) 
970 (21.8) 
834 (18.7) 
1,007 (22.6) 
56 (1.3) 
 
<0.001 
Looking for a paid job 
     Yes 
     No   
     Missing 
 
350 (8.6) 
3,277 (80.1) 
426 (11.3) 
 
17 (4.7) 
279 (76.8) 
67 (18.5) 
 
367 (8.2) 
3,556 (79.9) 
529 (11.9) 
 
<0.001 
Type of grant 
     Old age 
     Disability 
     None 
 
2,415 (59.1) 
153 (3.7) 
1,521 (37.2) 
 
211 (58.1) 
13 (3.6) 
139 (38.3) 
 
2,626 (59.0) 
166 (3.7) 
1,660 (37.3) 
 
0.914 
†
Chi square test p-value of difference between public and private healthcare facilities 
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Socio-demographic characteristics of the study participants by use of public or private health 
facilities are shown in Table 4. Overall, there were more female than male participants utilising 
the healthcare facilities (77% vs. 23%, p<0.001).  Of the 4,452 adults who visited healthcare 
facilities less than one year preceding the survey, 4,089 (92%) and 363 (8%) visited public and 
private healthcare facilities, respectively. Analysis to compare use of public and private 
healthcare facilities showed significant differences (p<0.05) in all socio-demographic 
characteristics, except age (p=0.093) and type of grant (p=0.914).  
4.1.3.1 Chronic disease profile 
Health-seeking behavior and disease profile are stratified by gender in Table 5. Of the 5,795 
respondents, 5,056 (87%) needed healthcare less than one year preceding the survey. Chronic 
NCDs were the most reported health problem (41%) with a higher occurrence in women than 
men (43% vs. 35%, p<0.001). In descending order, other reasons for needing healthcare less than 
one year preceding the survey included acute conditions - 27%, other conditions - 26%, chronic 
communicable disease (including HIV/AIDS) - 3%, and injuries - 3%. All 5,795 responders 
reported health problems, of whom 96% used healthcare, predominantly at public health 
facilities (82%). A subgroup (4,452 adults) of the total study participants who utilised public or 
private health facilities reported a higher use of the former than latter (92% vs. 8%, p<0.001) 
(96). Of the 5,056 adults who needed healthcare less than one year preceding the survey, 1,344 
(27%) were hospitalised while 274 (5%) had disabilities. There were significant differences 
(p<0.001) in health problems by gender, but there was no significant difference by gender in 
disability (p=0.353) and HCU (p=0.164).  
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Table 5: Health-seeking behaviour, by gender among 5,795 responders to the adult healthcare 
utilisation survey in the Agincourt sub-district in 2010 
Variables Women  
n (%) 
Men  
n (%) 
Total  
n (%) 
p-value
†
  
Last time healthcare was needed (n=5,795) 
      < 1 year 
      1 - 3 years 
      > 3 years 
 
3,863 (89.2) 
204 (4.7) 
266 (6.1) 
 
1,193 (81.6) 
84 (5.7) 
185 (12.7) 
 
5,056 (87.2) 
288 (5.0) 
451 (7.8) 
 
 
<0.001 
Health problems needing healthcare < 1 year 
before survey (n=5,056) 
    Non-communicable diseases* 
    Acute diseases** 
    Other diseases*** 
    Chronic communicable disease**** 
    Injuries 
 
 
1,649 (42.7) 
1,053 (27.3) 
977 (25.3) 
99 (2.6) 
85 (2.5) 
 
 
422 (35.4) 
295 (24.7) 
351 (29.4) 
71 (6.0) 
54 (4.5) 
 
 
2,071 (41.0) 
1,348 (26.6) 
1,328 (26.3) 
170 (3.4) 
139 (2.7) 
 
 
 
<0.001 
Hospitalisation < 1 year before survey 
(n=5,056) 
    No  
    Yes 
 
 
2,866 (74.2) 
997 (25.8) 
 
 
846 (70.9) 
347 (29.1) 
 
 
3,712 (73.4) 
1,344 (26.6) 
 
 
0.025 
Disability requiring treatment < 1 year before 
survey (n=5,056) 
      No 
      Yes 
 
 
3,660 (94.8) 
203 (5.2) 
 
 
1,122 (94.0) 
71 (6.0) 
 
 
4,782 (94.6) 
274 (5.4) 
 
 
0.353 
Healthcare utilisation by responders who 
needed healthcare < 1 year before survey 
(n=5,056) 
      No 
      Yes 
 
 
 
129 (3.3) 
3,734 (96.7) 
 
 
 
50 (4.2) 
1,143(95.8) 
 
 
 
179 (3.5) 
4,877 (96.5) 
 
 
 
0.164 
Actions taken by responders who utilised 
healthcare < 1 year before survey (n=4,877) 
    Public health facility 
    Private health facility 
    Other***** 
    Self-medication 
    Faith or traditional healer 
    None 
 
 
3,132 (83.9) 
239 (6.4) 
229 (6.1) 
105 (2.8) 
14 (0.4) 
15 (0.4) 
 
 
881 (77.1) 
120 (10.5) 
105 (9.2) 
28 (2.5) 
3 (0.2) 
6 (0.5) 
 
 
4,013 (82.3) 
359 (7.4) 
334 (6.9) 
133 (2.7) 
17 (0.3) 
21 (0.4) 
 
 
 
0.001 
†
Chi square test p-value of difference between gender  
* Hypertension, diabetes, stroke, sleep disorder, chronic pain in joints, depression, anxiety, 
cancer, heart problems 
** Fever and flu      
*** Musculoskeletal pain   
**** HIV and TB   
***** Change diet and exercise 
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4.1.3.2 Predictors of healthcare utilisation 
Table 6: Predictors of healthcare utilisation among 5056 adults aged 50+ who used healthcare 
less than one year before the survey in the Agincourt sub-district in 2010  
Variables Healthcare use (N=5056) 
Univariate binary logistic 
regression model 
OR (80% CI) 
Multivariate binary logistic 
regression model 
OR (95% CI) 
Age (years) 
   50 – 59 
   60 – 69 
   ≥ 70 
 
1 
1.05 (0.81 , 1.35) 
0.90 (0.71 , 1.13) 
 
Not included in the final 
model 
Gender 
   Male 
   Female 
 
1 
1.27 (1.02 , 1.57) 
 
1 
1.34 (0.96 , 1.89) 
Education (in completed years) 
   No formal education 
   ≤ 6 
   > 6 
 
1 
0.87 (0.70 , 1.08) 
2.49 (1.63 , 3.81) 
 
1 
0.85 (0.59 , 1.21) 
2.49 (1.27 , 4.86) 
Nationality of origin 
      Mozambique 
      South Africa 
 
1 
1.26 (1.03 , 1.55) 
 
1 
1.07 (0.76 , 1.49) 
Occupation 
Presently working for cash payment 
Not presently working for cash payment 
 
1 
1.09 (0.82 , 1.44) 
 
Not included in the final 
model 
Socioeconomic status 
    Lowest 
    Middle low 
    Middle 
    Middle high 
    Highest 
 
1 
0.84 (0.11 , 1.17) 
0.79 (0.58 , 1.09) 
1.12 (0.79 , 1.59) 
1.11 (0.79 , 1.55) 
 
 
 
Not included in the final 
model 
Looking for a paid job 
     No 
     Yes   
 
1 
0.70 (0.49 , 0.99) 
 
1 
0.75 (0.44 , 1.28) 
Type of grant 
     None 
     Old age 
     Disability 
 
1 
1.07 (0.87 , 1.31) 
1.63 (0.84 , 3.18) 
 
Not included in the final 
model 
Health problems   
    Acute conditions* 
    Chronic communicable disease** 
    Non-communicable diseases*** 
    Injuries  
    Other 
  
1 
5.51 (2.19 , 13.87) 
2.95 (2.32 , 3.76) 
2.97 (1.39 , 6.37) 
1.83 (1.44 , 2.33) 
  
1 
5.91 (1.44 , 24.32) 
2.85 (1.96 , 4.14) 
3.13 (0.97 , 10.08) 
1.83 (1.27 , 2.66) 
 
* Fever and flu         
** HIV and TB           
*** Hypertension, diabetes, stroke, sleep disorder, chronic pain in joints, depression, anxiety, cancer, heart 
problems 
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Chronic communicable diseases (e.g. HIV) and NCDs had significantly higher odds of predicting 
healthcare utilisation than acute conditions (Table 6). Similarly, more years of education 
predicted higher healthcare utilisation than no formal years of education (96).  
4.1.3.3 Reasons for not utilising healthcare 
The main reason for not utilising healthcare among the 4% who did not visit a health facility was 
not feeling sick enough (48%) - Figure 18. 
 
Figure 18: Reasons for not using healthcare among 179 adults who did not use healthcare less 
than one year before the survey in the Agincourt sub-district, 2010.  
NB: Reasons for not using healthcare were multiple response answers 
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4.2 Quality of care in the ICDM model 
4.2.1 General characteristics of the study population 
Table 7: Socio-demographic characteristics and chronic disease status of patients in the ICDM 
pilot and comparison facilities in the Bushbuckridge municipality 
Variable 
 
 
                     Study groups n (%) 
ICDM pilot 
 facilities 
(n = 435) 
Comparison 
facilities 
(n = 443) 
Total 
(n = 878) 
p-value of  
difference 
Age group (years) 
   18-29 
   30-39 
   40-49 
   50-59 
   ≥ 60 
   Missing 
 
19 (4.4) 
60 (13.8) 
59 (13.6) 
84 (19.2) 
197 (45.3) 
16 (3.7) 
 
39 (8.8) 
119 (26.9) 
92 (20.8) 
85 (19.2) 
105 (23.7) 
3 (0.6) 
 
58 (6.6) 
179 (20.4) 
151 (17.2) 
169 (19.2) 
302 (34.4) 
19 (2.2) 
 
<0.001 
Gender 
   Female 
   Male 
 
363 (83.4) 
72 (16.6) 
 
368 (83.1) 
75 (16.9) 
 
731 (83.3) 
147 (16.7) 
 
0.881 
Education (completed years) 
   No formal education 
   1-6 
   > 6 
   Missing 
 
172 (39.6) 
174 (40.0) 
71 (16.3) 
18 (4.1) 
 
167 (37.7) 
169 (38.1) 
73 (16.5) 
34 (7.7) 
 
339 (38.6) 
343 (39.1) 
144 (16.4) 
52 (5.9) 
 
0.170 
Looking for a paid job 
   Yes 
   No 
   Missing 
 
126 (29.0) 
291 (66.9) 
18 (4.1) 
 
120 (27.0) 
301 (68.0) 
22 (5.0) 
 
246 (28.0) 
592 (67.4) 
40 (4.6) 
 
0.725 
Type of grant 
   None 
   HIV 
   Disability 
   Old age 
   Missing 
 
202 (46.4) 
5 (1.2) 
15 (3.5) 
195 (44.8) 
18 (4.1) 
 
210 (47.4) 
8 (1.8) 
13 (2.9) 
190 (42.9) 
22 (5.0) 
 
412 (46.9) 
13 (1.5) 
28 (3.1) 
385 (43.9) 
40 (4.6) 
 
0.927 
Chronic disease status 
   Hypertension 
   HIV 
   Diabetes 
   Co-morbidities 
 
210 (48.3) 
141 (32.4) 
2 (0.5) 
82 (18.8) 
 
91 (20.5) 
282 (63.7) 
2 (0.5) 
68 (15.3) 
 
301 (34.3) 
423 (48.2) 
4 (0.5) 
150 (17.0) 
 
<0.001 
     
†
Chi square test p-value of difference between ICDM pilot and comparison facilities  
aAnalysis for diabetes patients was not done because of the small sample size (two in each study arm) 
bFive patients in the ICDM model facilities were transferred to other facilities also implementing the ICDM model. This was also 
the case for three patients in the comparison facilities. 
cTwo patients in the ICDM model facilities and one in the comparison arm were transferred to health facilities in other provinces 
dOne HIV patient died in the ICDM model study arm while three deaths (one hypertension and two HIV/AIDS patients) were 
recorded in the comparison facilities. 
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The response rate was 99%. Table 7 showed the mean age of the 435 hypertension, diabetes and 
HIV patients to be 55 ± 16 years in the cross-sectional quality of care study (Figure 12). Eighty-
three percent were females; 48% had no education; 29% looking for a paid job; and 45% 
received old age grants. Forty-eight percent (48%) of the patients were receiving treatment for 
hypertension and 32% were being managed for HIV/AIDS.  
 
In the qualitative study, there were 56 black adult participants (15 males and 41 females) in the 
eight FGDs. All seven operational managers who participated in the in-depth interviews were 
female professional nurses with an age range of 40-55 years and 15-20 years of nursing 
experience. A 55 year-old male senior health staff member was interviewed on behalf of the 
municipality health manager. A 55 year-old male senior sub-district health staff was interviewed 
on behalf of the sub-district health manager because the latter could not be interviewed due to 
busy administrative schedules. The race of the FGD participants reflects the dominance of black 
people in the study setting. The gender imbalance of the participants in the FGDs (15 males and 
41 females) corroborates the gender constitution of the population in the study setting (female vs. 
male: 70% vs. 30%) and the gender composition of the 345 patients from which the FGD 
participants were recruited (female vs. male: 83% vs. 17%) (Ameh et al., under review). 
4.2.2 Satisfaction with the dimensions of services in the ICDM model 
This subsection describes the results on satisfaction with the dimensions of services in the ICDM 
model which have been categorised into quantitative and qualitative components. The 
quantitative component focuses on comparing satisfaction of patients and operational managers 
with the 17 dimensions of care. The quantitative findings are complemented by the qualitative 
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result showing the depth and breadth of patient and provider satisfaction with services in the 
ICDM model.  
4.2.2.1 Satisfaction with structure-related dimensions of care in the ICDM model 
Figure 19 showed that the patients (P) and operational managers (OM) reported being satisfied 
(scores ≥ 50%) with all the structure-related dimensions of care in the ICDM model. There were 
no statistically significant differences (p>0.05) between the satisfaction scores of the patients and 
operational managers with structure-related dimensions of care, except for availability of 
equipment (S1): P-97% vs. OM-52%, p<0.001. 
 
Figure 19: Satisfaction scores of the patients and operational managers with structure-related 
dimensions of care in the ICDM model  
 
* Priority dimensions of care in the ICDM model  
† Statistically significant differences in the satisfaction scores of the patients and operational 
managers 
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The next section shows the results of the qualitative analysis of the availability of the structure-
related ICDM policy, and satisfaction of patients and operational managers with structure-related 
dimensions of care.  
 
The ICDM policy 
We have got the ICDM manual to guide us on how to implement the ICDM model in the PHC 
facilities [Municipal health manager]. 
The municipal health manager reported use of the ICDM treatment manual by professional 
nurses in the ICDM pilot facilities when interviewed on the availability of a policy document to 
create an enabling environment for the implementation of the ICDM model in health facilities. 
 
Patient and provider narratives on satisfaction with structural dimensions of care showed the 
following results: 
Critical medicines 
Patients reported inconsistent supply of critical medicines for the treatment of hypertension in 
the health facilities.  
When my treatment is not available at the clinic they do tell me that this month my 
treatment is not available; then they gave me the one that is available that day. When the 
treatment is not out of stock, they do give me all the treatment that I am getting every 
month [Respondent 2 (man), Clinic 1]. 
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In this study, hypertension patients reported receiving monthly prescribed medication when there 
was a regular supply of medicines. However, there were occasional drug stock-outs in some 
health facilities; hence, the frustration of patients with irregular supply of anti-hypertension 
medicines. 
 
Equipment 
Hypertension patients reported concern for the lack of functioning blood pressure (BP) machines 
in the health facilities they received care. 
We have stayed for two to three months without BP machine. They were just giving us 
treatment without knowing whether our BP was high or not. … It gives us problem when 
we have to travel to another clinic to check our BP [Respondent 1 (woman), Clinic 7]. 
 
Patients thought it was abnormal to not have their BP checked by nurses while taking anti-
hypertensive drugs. Patients described their experiences of travelling to other health facilities 
with functioning BP machines to ascertain whether or not their BP was under control.  
 
An operational manager acknowledged that her health facility did not have functioning BP cuffs 
(a component of BP equipment tied in the arm) and other medical equipment. 
[She laughs] what can I say? I think three weeks back Mr. X [a project site manager at 
institution Y] was here to give us different kinds of BP cuffs because we didn’t have them. 
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I really can’t say that the clinic has all the different medical equipment to take care of all 
those patients or bring quality nursing care to the patients [Operational Manager, clinic 
3]. 
This operational manager expressed frustration in her ability to provide quality care to patients 
due to the lack of equipment. She further indicated that a project manager working in a non-
governmental research institution donated BP cuffs to her health facility to enable nurses to 
monitor patients‘ BP more effectively. 
4.2.2.2 Satisfaction with process-related dimensions of care in the ICDM model 
Figure 20 showed that the operational managers reported being satisfied (scores ≥ 50%) with all 
process-related dimensions of care in the ICDM model. However, the patients were not satisfied 
(scores < 50%) with defaulter tracing of patients (P7-29%) and appointment systems (P14-20%). 
Of all the process-related dimensions of care, there were statistically significant differences in 
the scores of the patients and operational managers in appointment system (P14): P-20% vs. 
OM-100%, p<0.001; physical examination of patients (P11): P-96% vs. OM-57%, p<0.001; 
defaulter tracing of patient (P7): P-29% vs. OM-86%, p=0.001; hospital referral of patients (P5): 
P-62% vs. OM-100%, p=0.039; and friendliness of the nurses to patients (P4): P-92% vs. OM-
71%, p=0.041. 
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Figure 20: Satisfaction scores of the patients and operational managers with process-related 
dimensions of care in the ICDM model 
 
* Priority dimensions of care in the ICDM model  
† Statistically significant differences in the satisfaction scores of the patients and operational managers 
Qualitative analysis showed the following results in the process-related dimensions of care in the 
ICDM model. 
Prepacking drugs  
The ICDM manual stipulates that nurses prepack patients‘ medicines before patients‘ arrival at 
the facilities to reduce patient waiting time during consultation with nurses. The nurses‘ inability 
to regularly prepack medicines was reported as a factor militating against the delivery of 
services. 
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Sometimes we do prepacking the day before clinic appointment. Sometimes when we are 
short-staffed, we are unable to do it. Another challenge is that we don’t have prepacking 
bags [Operational Manager, Clinic 4]. 
 
A narrative from an operational manager showed that prepacking patients‘ drugs before 
scheduled appointments was done sometimes in her health facility. The manager identified staff 
shortage and unavailability of prepacking bags as obstacles to regular prepacking of patients‘ 
drugs before clinic visits. Hence, prepacking was sometimes done during or after consultation 
with nurses or it was not done in instances when there were no prepacking bags.   
Appointment system 
Patients reported a rigid appointment system in which they were unable to access services for 
sudden-onset illnesses occurring before their scheduled appointment dates. 
 When your date is still far you can’t go to the clinic even when you have other illnesses 
[Respondent 2 (woman), Clinic 3].  
In the ICDM model of care, patients with chronic diseases are given appointment dates for their 
next clinic visits. These predetermined scheduled appointments are usually on a monthly basis 
for unstable/uncontrolled cases [e.g. BP>140/90 mmHg for hypertension patients and CD4 count 
< 350 cells/mm
3
for HIV patients] or two monthly for stable/controlled cases [e.g. BP<140/90 
mmHg for hypertension patients and CD4 count > 350 cells/mm
3
for HIV patients].  
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Patients also reported that those of them who missed previous clinic appointments were being 
made to wait in the queues during subsequent visits until nurses had attended to patients who 
were on the appointment list for that day; hence, one of the reasons constituting long patient 
waiting time.   
When they [nurses] shout at us it is because when they tell you to come today at nine, you 
find that you miss your appointment date and come at another day. When I missed my 
appointment and went there the other day, they [nurses] delayed me even when I arrived 
at the clinic early. All the patients that came after my arrival collected their treatment 
and went home and left me at the clinic. And I don’t think they [nurses] are wrong 
because you [patient] are the one who missed your appointment [Respondent 2 (woman), 
Clinic 1]. 
Home-Based Carer process factors 
Patients reported that home-based carers (HBCs) who visited patients in their homes divulged 
their clients‘ clinical details to people in the neighbourhood. 
I told them [HBCs] not to come to my house any more. When I tell them something, I 
expect them to report it to their seniors and not to tell the whole community. So when I’m 
sick, I will go to the clinic [Respondent 5 (woman), Clinic 2]. 
 
Patients recognised the role of home-based carers [HBCs] in patient management such as 
assisting patients with domestic chores and delivering their drugs from the health facilities. 
However, some patients reported that HBCs breached their clients‘ confidentiality by disclosing 
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their clinical information to persons other than those entrusted with patient care and 
management.  
 
An operational manager described a situation in which community members stigmatised ill 
people who were visited by HBCs. 
Home-based carers are not accepted. They [patients] are thinking that other people 
[community members] will think that they are HIV positive and that is why the HBCs are 
coming to visit them [Operational manager, Clinic 1]. 
 
Community members were said to have perceived patients visited by HBCs to be ill due to 
HIV/AIDS; hence, the justification for the home-based care and visits. Such patients responded 
by not allowing HBCs to visit their homes. This reported HIV-related stigma constitutes a 
community barrier to accessing health services. 
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Nurse- and patient-related process factors 
Operational managers and patients reported diverging viewpoints of how behaviours expressed 
by healthcare providers and users influenced process factors in the health facilities.  In the quote 
below, a patient expressed dissatisfaction with the professional conduct of a nurse. 
When you are in the consulting room with her [referring to a nurse], she will send you to 
go and take the tablets in the locker [referring to where drugs are kept]. Do I know the 
tablets I have to use? Sometimes she will send a cleaner to go and take the tablets; does 
the cleaner know the treatment? I have seen it several times and am saying that these 
nurses are going to kill us [Respondent 2 (woman), Clinic 4].  
 
On the other hand, an excerpt below indicates how an operational manager noted that patients 
challenged the ability of HBCs to trace clinic defaulters who resorted to traditional means of 
seeking healthcare in places far away from where they [patients] received biomedical care.  
We [nurses] have tried our level best even to trace patients who missed their appointment 
using HBCs and by telephone calls. Some of our patients move around seeking care in 
many places because they believe in both western civilization treatment and traditional 
healers. You find that a patient is receiving treatment in village X and the next thing you 
will hear from the relative that he (the patient) is at village Y [about 50 Km away from 
village X] because there is a traditional healer there who is busy treating him. That gives 
us a problem in tracing them [Operational manager, Clinic 3]. 
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4.2.2.3 Satisfaction with outcome-related dimensions of care in the ICDM model 
Figure 21 showed that the patients and operational managers reported being satisfied (scores ≥ 
50%) with three of the four outcome-related dimensions of care in the ICDM model.  On the 
other hand, the patients and operational managers were not satisfied (scores < 50%) with patient 
waiting time (O4): P-17% vs. OMs-43%. A comparison of the satisfaction scores of the patients 
and operational managers with all the outcome-related dimensions of care showed no statistically 
significant differences (p>0.05). 
 
 
Figure 21: Satisfaction scores of the patients and operational managers with outcome-related 
dimensions of care in the ICDM model 
 
* Priority dimensions of care in the ICDM model  
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In the qualitative analysis, reduced stigma attributable to coherent integrated services and long 
waiting time were reported as out-related dimensions of care in the ICDM model.  
Reduced stigma 
An operational manager reported that coherence and integration of services conferred an 
advantage on people living with HIV (PLWHIV) because of reduced stigma due to non-
segregation of patients managed for chronic disease in the same clinic in the health facilities.  
Previously we were grouping them according to their diseases, but now they are put 
together. Patients living with HIV/AIDS are satisfied because they are mixed with those 
who are having hypertension and diabetes (Operational Manager, Clinic 6). 
 
Reduced HIV stigma was attributed to the innovative integrated chronic disease services in 
which patients were not segregated or attended to by nurses based on their disease status. Non-
segregation of patients or consultation rooms in the clinics implied that it may not have been 
easy for patients to identify who was being managed for HIV/AIDS; hence, the reduced HIV-
related stigma. 
Long waiting time 
Patients and operational managers reportedly attributed long patient waiting time in the health 
facilities in this study to several factors. Patients said waiting time was long due to late arrival of 
filing clerks and nurses; long morning prayer sessions before commencement of clinical duties; 
staff meetings; prolonged tea or lunch breaks; nurses giving preferential treatment to friends or 
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relatives who skip the queues; and nurses engaging in trading activities (e.g. buying and selling 
of household products) in the consultation room during consultation hours.  
We arrive at six in the morning and stay outside the gate and they will open the gate at 
eight o’clock. Sometimes they will start to check you at one o’clock. You will get your 
treatment very late despite early arrival at the clinic [Respondent 2 (man), Clinic 7]. 
 
On the other hand, operational managers reported long waiting time was due to staff shortage 
and patients missing their clinic appointments. 
We are booking a certain number of patients and if that number becomes extra because 
of those who didn’t come on their appointment dates; you find that we have a lot of 
patients and they (those who missed their previous appointment) have to wait 
(Operational Manager, Clinic 1). 
4.2.2.4 Emerging themes from the qualitative study 
Staff shortage and inability to afford costs of transportation to health facilities were reported as 
emerging themes in the qualitative analysis. 
Staff shortage 
Operational managers and patients identified staff shortage as a key human resource challenge 
impacting the delivery of quality care in the health facilities. 
I’m alone and I have to do all the programmes with the staff nurse. I’m to manage the 
deliveries, antenatal clinics, integrated chronic disease clinic, minor illness, 
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immunization and all those programmes. I can’t! ….. Sometimes if I am forced to do the 
work alone I end up making some stupid mistakes (Operational Manager, clinic 3). 
Today, they [referring to nurses] are two and they get tired and become complicated 
[Respondent 1 (woman), Clinic 6]. 
 
An operational manager reported making mistakes due to work overload arising from staff 
shortage. A patient described how staff shortage in a health facility led to work-related 
exhaustion and ‗complicated‘ behaviour of nurses, an indication of how the lack of adequate 
human resources negatively impacts the provision of quality services.  
Inability to afford costs of transportation 
Patients reported inability to afford costs of transportation as a barrier to accessing clinics or 
when referred by nurses, from clinics to doctors in the hospitals.  
If I am working for someone and that person doesn’t pay me, I have to wait until the 
person pays me before I have to go to the clinic or hospital [Respondent 4 (woman), 
Clinic 1]. 
 
In a rural South African setting with high unemployment levels, people‘s reliance on paid jobs as 
means of livelihood also affected their healthcare seeking behaviour. Delay in clinic or hospital 
visits was influenced by late payment for services rendered. 
  
 90 
 
4.2.3 Quality of care 
This subsection shows the relationships between structure, process, and outcome constructs as a 
measure of quality of care in the ICDM model using patient satisfaction scores.  
4.2.3.1 Relationships between structure, process and outcome constructs  
Figure 22 showed the result of the relationships between structure, process and outcome 
constructs as a measure of quality of care in the ICDM model assessed using structural equation 
model. The Cronbach‘s alpha coefficients of reliability of all variables intended for their 
respective SPO constructs ranged from acceptable to good: structure (0.790), process (0.702), 
and outcome (0.600), an indication that the variables were a reliable measure of their intended 
constructs (85). 
 91 
 
 
Figure 22: Goodness-of-fit, reliability and correlation assessment of the relationships between 
structure, process and outcome 
 
*Relationships between the constructs represented by the Pearson correlation values  
NB: The dimensions in red colour are the priority areas of the ICDM model 
 
RMSEA - Root Mean Squared Error of Approximation (≤ 0.06 is a good fit) 
CFI - Comparative Fit Index (CFI ≥ 0.90 is a good fit) 
TLI - Tucker-Lewis Index (TLI ≥ 0.90 is a good fit) 
CD - Coefficient of determination (range 0-1. There is a perfect fit of the data with the model if CD=1) 
Cronbach’s alpha coefficient of reliability (≥ 0.6 is acceptable) 
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Before running confirmatory factor analysis (CFA), six negatively phrased statements (S3, P6, 
P8, P10, P13 and O2) in the adapted questionnaire were dropped because there was no evidence 
of acquiescent response set (ARS) in the pair of statements phrased in opposite directions (Figure 
23).  
 
Figure 23: Agreement with positive statements and disagreement with negative statements  
 
* Priority dimensions of care in the ICDM model  
 
In assessing the fit of the constructs and the remaining 17 variables, three process-related 
variables: communication with patients (P1), hospital referral (P5) and physical examination of 
patients (P11) with coefficient of determination values < 0.20 were dropped (86). Of the 
remaining 14 variables, four process-related variables: defaulter tracing of patients (P7), 
prepacking of drugs before clinic visit (P9), time patients spent with nurses during consultation 
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(P12) and appointment system (P14); and one outcome-related variable: patient waiting time 
(O4) did not load significantly (factor loadings < 0.3) onto their intended constructs in the CFA 
(Table 8), and were dropped after CFA. 
Table 8: Factor loading of variables intended for structure, process and outcome constructs in the 
assessment of quality of care in the ICDM model 
Constructs Variables Loading Standard error 
Structure    
 Availability of equipment (S1) 0.462* 0.038 
    Supply of critical medicines (S2) 0.994* 0.012 
 Accessibility of services (S4) 0.383* 0.041 
Process    
 Attendance to patients‘ needs (P2) 0.664* 0.035 
 Professionalism (P3) 0.758* 0.032 
 Friendliness (P4) 0.669* 0.035 
 Defaulter tracing (P7) 0.200 0.056 
 Prepacking of drugs (P9) 0.268 0.055 
 Time spent with nurses (P12) 0.074 0.056 
 Appointment system (P14) 0.163 0.053 
Outcome    
 Coherence (O1) 0.310* 0.057 
 Competence (O3) 0.485* 0.053 
 Waiting time (O4) 0.229 0.058 
 Confidence (O5) 0.651* 0.054 
*Variables with factor loading ≥ 0.300  
 
Nine variables reflected their intended SPO constructs (factor loading > 0.300) in the structural 
equation model (Figure 22). These were three structure-related dimensions: availability of 
equipment (S1), supply of critical medicines (S2) and accessibility of chronic disease care (S4); 
three process-related dimensions: attending to patients‘ health needs (P2), professional conduct 
of the nurses (P3) and friendliness of the nurses (P4); and three outcome-related dimensions: 
coherence of integrated chronic disease care (O1), patient confidence in the nurses (O3), and 
competence of the nurses (O5).  
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The fit indices of the three specified pathways are as follows: (a) unidirectional pathway - 
[χ2[52]=145, p<0.001; RMSEA=0.064 (90% CI - 0.052-0.077); CFI=0.915; TLI=0.892; 
CD=0.911], (b) mediation pathway - [χ2[52]=127, p<0.001; RMSEA=0.058 (90% CI - 0.045-
0.070); CFI=0.931; TLI=0.913; CD=1.00] and (c) reciprocal pathway – [χ2[59]=147, p<0.001; 
RMSEA=0.059 (90% CI - 0.047-0.070); CFI=0.919; TLI=0.910; CD=0.632].  
 
Table 9 showed that when using at least two criteria, all the specified path models fit the data, 
but only the mediation pathway fulfilled all the criteria used except the chi-squared criterion, 
which is expected because the sample size of this study was greater than 400. In addition, the 
mediation pathway showed a perfect fit with a CD value of 1.00.  
 
Table 9: Goodness of fit of the specified path models in evaluating the quality of care in the 
ICDM model 
 
Criteria 
Specified path models 
Unidirectional Mediation Reciprocal 
χ2 test p value > 0.05* P<0.001 P<0.001 P<0.001 
RMSEA value ≤ 0.06 0.064 
(90% CI - 0.052-0.077) 
0.058 
(90% CI - 0.045-0.070) 
0.059 
(90% CI - 0.047-0.070) 
CFI ≥ 0.90 0.915  0.931  0.919 
TLI ≥ 0.90 0.892 0.913  0.910 
CD close to 1.00 
(perfect fit is preferred 
if CD value=1.00) 
0.911   1.00  0.632 
Ranking** 3
rd
 1
st
 2
nd
 
Show goodness of fit 
**The mediation model ranked first because it fulfilled four criteria (RMSEA, CFI, TLI and CD). In 
addition, it showed a perfect fit based on CD value of 1.00 
 **The reciprocal model ranked second because it fulfilled three criteria (RMSEA, CFI and TLI) 
**The unidirectional model ranked third because it fulfilled two criteria (CFI and CD). However, it did 
not show a perfect fit based on CD value of 0.911 
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4.3 Changes in patients’ health outcomes attributable to the ICDM model 
4.3.1 General characteristics of the study population 
For the controlled interrupted time series study conducted to assess changes in patient‘s health 
outcomes attributable to the ICDM model,  Table 5 showed that a significantly (P<0.001) higher 
percentage of patients in the ICDM pilot (67%) than the comparison (43%) facilities were aged 
50 years and older. There were no statistically significant differences (p>0.05) between the study 
populations by other socio-demographic variables. The percentage of hypertension patients was 
significantly higher in the ICDM pilot facilities (48% vs. 21%; P<0.001) whereas the 
comparison facilities had more HIV/AIDS patients (64% vs. 32%; P<0.001).  
4.3.2 Changes in patients’ health outcomes 
This subsection presents the results of the effectiveness of the ICDM in improving patients‘ CD4 
counts and blood pressure. 
4.3.2.1 Health outcomes of HIV patients 
The ARMA (1,1) model in Table 10 showed statistically significant coefficients of 0.68 (95% 
CI: 0.64,0.72; P<0.001) for the autoregressive (AR) and -0.81 (95% CI: -0.85,-0.78; P<0.001) 
for the moving average (MA) component. Overall, the pilot facilities had a 5.7% greater 
likelihood of controlling patients‘ CD4 counts than the comparison facilities (coef=0.057; 95% 
CI: 0.056,0.058; P<0.001) given that both study arms had 91% likelihood of controlling patients‘ 
CD4 count (constant in Table 10). The interaction of study groups and time in Table 10 showed 
that CD4 count control was greater by 0.2% in the pilot than comparison facilities during the 24 
months of implementation of the ICDM model (coef=0.002; 95% CI: 0.001,0.003; P<0.001).  
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Table 10: The autoregressive moving average model for CD4 count control in primary health 
care facilities in the Bushbuckridge municipality from January 2011 to June 2013 
Variables Coefficient Standard 
error 
Confidence 
interval 
p-value 
Reference attributes 
   Comparison facilities 
   Pre-intervention period 
    
   ICDM pilot facilities 0.057 0.0002 0.056,0.058 <0.001 
   Post-intervention period   -0.003 0.0001 -0.004,-0.002 <0.001 
   ICDM pilot*Post-intervention period 0.002 0.0003 0.001,0.003 <0.001 
 
   Constant 
 
0.91 
 
0.0001 
 
0.90,0.92 
 
<0.001 
Autoregressive moving average (ARMA) 
modeling 
    
   Autoregressive component (L1) 0.68 0.0212 0.64,0.72 <0.001 
   Moving average component (L1) -0.81 0.0185 -0.85,-0.78 <0.001 
 
 
The residuals in Figure 24 below show a good normal distribution confirming the good fit of the 
model and the data. 
 
Figure 24: Monthly probabilities of having a CD4 count > 350 cells/mm3 by study groups 
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*Dotted gray lines show the month the ICDM model was initiated. 
The probability of controlling patients‘ CD4 counts in the pilot and comparison facilities 
decreased in the six month period before initiation of the ICDM model. However, this decrease 
nearly stabilised in both study arms during the 24 months of implementation of the ICDM model 
in the pilot facilities (Figures 25 and 26). After propensity score matching, there was a reduction 
in the differences in the probability of controlling patients‘ CD4 counts between the pilot and 
comparison facilities (Figures 25 and 26). Figure 26 showed that the pilot facilities had a 
consistently higher probability of controlling patients‘ CD4 counts than the comparison facilities 
six months before the initiation of the ICDM model (97.5% vs. 94.5%) and two years after the 
model was implemented (96.5% vs. 94.0%). 
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Figure 25: Monthly probabilities of having a CD4 count > 350 cells/mm3 by study groups before 
propensity score matching.  
*Dotted gray line shows when the ICDM model was initiated. 
 
 
 
Figure 26: Monthly probabilities of having a CD4 count > 350 cells/mm3 by study groups after 
propensity score matching. 
*Dotted gray line shows the month the ICDM model was initiated. 
 
The segmented linear regression results in Table 11 (section A) showed a 0.26% monthly 
decrease in the probability of patients having a controlled CD4 count before the initiation of the 
ICDM model in the pilot facilities (coef = -0.0026; 95% CI: -0.0027,-0.0025; P<0.001). After 
the initiation of the model, the probability of patients having a controlled CD4 count decreased 
month-in-month by 0.03% (coef = -0.00032; 95% CI: -0.00033,-0.00031; P<0.001). Hence, there 
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was a 0.23% reduction in the decreasing monthly probability of controlling CD4 counts observed 
at baseline (coef = -0.0023; 95% CI: -0.0026,-0.0021; P<0.001).  
In the comparison facilities (Table 11, section B), the monthly changes in the probability of 
patients having a controlled CD4 count decreased monthly by 0.17% (coef = -0.0017; 95% CI: -
0.0024,-0.0010; P<0.001) and 0.02% (coef = -0.00018; 95% CI: -0.00024,-0.00013; P<0.001) 
before and after the initiation of the ICDM model, respectively. The decreasing monthly trend 
for CD4 count control observed before the initiation of the ICDM model was reduced by 0.15% 
during implementation of the ICDM model (coef = -0.0015; 95% CI: -0.0022,-0.0008; P<0.001). 
Table 11: Estimated level (intercept) and trend (slope) changes in controlled CD4 counts (> 350 
cells/mm3) following implementation of the ICDM model in the ICDM pilot and comparison 
health facilities in the Bushbuckridge municipality from January 2011 to June 2013 
Estimates Pre-intervention period Post-intervention period 
Section A 
ICDM pilot facilities 
Intercept Trend Intercept Trend 
Coefficient (%)  
Standard error 
p-value 
95% confidence interval 
2.56 
0.03 
<0.001 
2.49,2.63 
-0.0026 
0.00005 
<0.001 
-0.0027,-0.0025 
1.17 
0.004 
<0.001 
1.16,1.18 
-0.00032 
0.00005 
<0.001 
-0.00033,-
0.00031 
Change in trend Coefficient= -0.0023; 95% CI= -0.0026,-0.0021; p<0.001 
Section B 
Comparison facilities 
Intercept Trend Intercept Trend 
Coefficient (%)  
Standard error 
p-value 
95% confidence interval 
1.96 
0.22 
<0.001 
1.53,2.39 
-0.0017 
0.0004 
<0.001 
-0.0024,-0.0010 
1.06 
0.02 
<0.001 
1.03,1.10 
-0.00018 
0.00003 
<0.001 
-0.00024,-
0.00013 
Change in trend Coefficient= -0.0015; 95% CI= -0.0022,-0.0008; p<0.001 
*Segmented linear regression analysis after propensity score matching 
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4.3.2.2 Health outcomes of hypertension patients 
The ARMA (1,2) model for BP control showed a significant coefficient of 0.47 (95% CI: 
0.35,0.58; P<0.001) for the AR component. The MA parts were also statistically significant at 
coefficients of -0.46 (95% CI: -0.55,-0.37; P<0.001) and 0.33 (95% CI: 0.28,0.38; P<0.001) - 
Table 12. Overall, the pilot facilities had a 1.0% greater chance of controlling BP than the 
comparison facilities (coef=0.010; 95% CI: 0.003,0.016; P=0.002) given that 50% or more of the 
patients in both study arms were likely to have their blood pressure controlled (constant in Table 
12). The interaction between the study groups and time showed the pilot facilities had a 3.6% 
greater chance of controlling BP than the comparison facilities during the 24 months of 
implementation of the ICDM model (coef=0.036; 95% CI: 0.029,0.043; P<0.001).  
Table 12: The autoregressive moving average model for blood pressure control in primary health 
care facilities in the Bushbuckridge municipality from January 2011 to June 2013 
Variables Coefficient Standard 
error 
Confidence 
interval 
p-value 
Reference attributes 
   Comparison facilities 
   Pre-intervention period 
    
   ICDM pilot facilities 0.010 0.0031 0.003,0.016 0.002 
   Post-intervention period  -0.030 0.0030 -0.036,-0.024 <0.001 
   ICDM pilot*Post-intervention period 0.036 0.0029 0.029,0.043 <0.001 
    
Constant 
 
0.50 
 
0.0030 
 
0.49,0.51 
 
<0.001 
Autoregressive moving average (ARMA) 
modeling 
    
   Autoregressive component (L1) 0.47 0.0576 0.35,0.58 <0.001 
   Moving average component (L1) 
   Moving average component (L2) 
-0.46 
0.33 
0.0480 
0.0272 
-0.55,-0.37 
0.28,0.38 
<0.001 
<0.001 
 
 
Figure 27 below showed a reasonable normal distribution of the residuals for BP control except 
for a slight skewness to the right due to a few extreme values. 
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Figure 27: Monthly probabilities of having a BP < 140/90 mmHg by study groups  
*Dotted gray lines show the month the ICDM model was initiated. 
 
 
There was a decreasing probability of patients having a controlled BP in the pilot and 
comparison facilities before the ICDM model was initiated and this decrease was more rapid in 
the pilot than in the comparison facilities (Figures 28 and 29). Following initiation of the ICDM 
model, there was a reduction in the decreasing probability of controlling patients‘ BP in both 
study arms and this was much more so in the pilot than in the comparison facilities. The ICDM 
model appeared to have reduced the steep downward slope for the control of patients‘ BP 
observed in the pre-ICDM model period (Figures 28 and 29). A comparison of the two study 
arms in Figure 29 showed a consistently higher probability of controlling patients‘ BP in the 
pilot facilities than in the comparison facilities six months before the initiation of the ICDM 
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model (50% vs. 47%) and two years after the model was implemented (47% vs. 40%). The pilot 
facilities also had less zig-zag fluctuations in BP control than the comparison facilities. 
 
 
Figure 28: Monthly probabilities of having a BP < 140/90 mmHg by study groups before 
propensity score matching. 
*Dotted gray line shows the month the ICDM model was initiated. 
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Figure 29: Monthly probabilities of having a BP < 140/90 mmHg by study groups after 
propensity score matching. 
*Dotted gray line shows the month the ICDM model was initiated. 
 
The segmented regression analysis in Table 13 (section A) showed a 1.6% monthly decrease in 
the probability of controlling patients‘ BP in the pre-ICDM model intervention period in the pilot 
facilities (Coef= -0.016; 95% CI: -0.017,-0.015; P<0.001). During the 24 months of 
implementation of the model, there was a 0.11% decrease in the probability of patients having 
their BP controlled (Coef= -0.0011; 95% CI: -0.0012,-0.0010; P<0.001).  A pre-post initiation 
comparison of the change in trend showed that the steeply decreasing probability of controlling 
patients‘ BP observed  before initiation of the model was cut back by 1.5% (Coef= -0.015; 95% 
CI: -0.016,-0.014; P<0.001).  
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There was a 0.2% monthly decrease in the probability of patients having a BP < 140/90 mmHg 
in the comparison facilities (coef = -0.002; 95% CI: -0.004,-0.001; P=0.001) - Table 13, section 
B. During implementation of the model, the probability of patients having a controlled BP 
decreased monthly by 0.09% (coef = -0.0009; 95% CI: -0.0011,-0.0008; P<0.001). Hence, the 
pre-post initiation change in trend showed a 0.1% cut back in the steeply decreasing probability 
of controlling patients‘ BP observed in the pre-ICDM model era (coef = -0.001; 95% CI: -
0.0028,-0.0001; P<0.001) – Table 13, section B. 
Table 13: Estimated level (intercept) and trend (slope) changes in controlled blood pressure (< 
140/90 mmHg) following implementation of the ICDM model in the ICDM pilot and 
comparison health facilities in the Bushbuckridge municipality from January 2011 to June 2013 
 
Estimates Pre-intervention period Post-intervention period 
Section A 
ICDM pilot facilities 
Intercept Trend Intercept Trend 
Coefficient (%)  
Standard error 
p-value 
95% confidence interval 
10.3 
0.20 
<0.001 
9.90,10.70 
-0.016 
0.0003 
<0.001 
-0.017,-0.015 
1.13 
0.02 
<0.001 
1.09,1.18 
 
-0.0011 
0.00004 
<0.001 
-0.0012,-0.0010 
Change in trend Coefficient= -0.015; 95% CI= -0.016,-0.014; p<0.001 
Section B 
Comparison facilities 
Intercept Trend Intercept Trend 
Coefficient (%)  
Standard error 
p-value 
95% confidence interval 
1.87 
0.44 
<0.001 
1.00,2.73 
 
-0.002 
0.0007 
0.001 
-0.004,-0.001 
1.01 
0.04 
<0.001 
0.94,1.08 
 
-0.0009 
0.00006 
<0.001 
-0.0011,-0.0008 
Change in trend Coefficient= -0.001; 95% CI= -0.0028,0.0001; p<0.001 
*Segmented linear regression analysis after propensity score matching 
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Appendix 6 showed the number of monthly visits of sampled patients who utilised PHC facilities 
from January 2011 to June 2013 in the two study arms. These monthly visits which have been 
stratified by hypertension and HIV showed a fluctuating pattern of health care utilisation. 
4.4 Summary of the results of the three themes 
Table 14 below summarises the results of this thesis by presenting how the four papers cover the 
three research themes and address the four research objectives. 
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Table 14: Summary of the key findings of the themes by papers 
 
Themes 
Key findings by papers 
Paper I Paper II Paper III Paper IV 
Chronic disease profile 
and predictors of 
healthcare utilisation 
Research objective 1: 
What were the main 
chronic diseases and 
predictors of healthcare 
utilisation by adults 50 
years and older in 2010, 
the year before the ICDM 
model was initiated? 
 
 
1. High prevalence 
of self-reported 
NCDs in the 
population 
2. Low prevalence 
of self-reported 
HIV/AIDS in the 
population 
3. HIV/AIDS and 
NCDs were the 
main predictors of 
healthcare 
utilisation in adults 
aged 50 years and 
older  
 
 
 
 
  
  
 
 
 
 
Quality of care in the 
ICDM model  
Research objective 2 
(Quantitative method): 
What was the quality of 
care in the ICDM model? 
 
 
 
 
 
 
 
  
1. Operational managers 
reported satisfaction with all 
dimensions of care in the ICDM 
model except patient waiting 
time (Figure 19). 
2. Patients reported satisfaction 
with all dimensions of care in 
the ICDM model except 
appointment system, defaulter 
tracing of patients and patient 
waiting time (Figures 16-18). 
3. The mediation path model 
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Themes 
Key findings by papers 
Paper I Paper II Paper III Paper IV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Research objective 3 
(Qualitative method): 
How did the patients and 
operational managers 
perceive the quality of 
chronic disease care in the 
ICDM model?  
 
 
 
had the best goodness of fit. 
This implies that structure 
construct directly influenced 
process construct which in turn 
directly influenced outcome 
construct.  
Structure construct directly 
influenced outcome construct 
without the mediating effect of 
process construct. (Figure 22). 
 
Nine of the 17 dimensions of 
care assessed were significantly 
associated with good quality of 
care in the ICDM model. Of the 
eight priority areas, supply of 
critical medicines and coherence 
of care were significantly 
associated with good quality of 
care (Figure 22).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Nurses thought there 
was reduced HIV-related 
stigma because patients 
receiving treatment for 
HIV and NCDs attended 
same clinic.  
2. Nurses and patients 
reported occasional anti-
hypertension drug stock-
outs, malfunctioning 
blood pressure machines, 
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Themes 
Key findings by papers 
Paper I Paper II Paper III Paper IV 
 
 
 
  
staff shortage, 
dysfunctional prepacking 
of drugs and long patient 
waiting time.  
3. Nurses and patients 
reported diverging 
opinions on defaulter 
tracing activities rigid 
clinic appointments and 
defaulter tracing 
activities. 
4. Emerging themes 
were staff shortage and 
patients‘ inability to 
afford the cost of 
transportation to the 
health facilities and 
hospitals 
Theme 3: Changes in 
patients’ health outcomes 
attributable to the ICDM 
model  
Research objective 4: 
Was the ICDM model 
effective in controlling 
patients‘ CD4 count 
(>350cells/mm
3
) and blood 
pressure (<140/90 
mmHg)? 
   The ICDM model 
appears to have 
decreased the 
downward 
trajectory in the 
control of CD4 
counts and blood 
pressure observed 
in the period before 
the initiation of the 
model.  
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5.0 Discussion 
This thesis evaluated the use of an ICDM model to address management of HIV and 
hypertension in selected PHC facilities in a typical rural South African municipality. The dual 
burden of HIV and NCDs in a rural setting in South Africa was also explored in this thesis.  
 
The next sections discuss the results of this thesis which have been organised into three thematic 
areas: chronic disease profile and predictors of healthcare utilisation in the population, quality of 
care in the ICDM model and changes in patients‘ health outcomes attributable to the ICDM 
model.  
5.1 Chronic disease profile and predictors of healthcare utilisation 
 
 
 
 
A high prevalence of NCDs (41%), particularly hypertension, was self-reported by adults 50 
years and over in the study area. This high prevalence of hypertension was previously reported in 
the study area (4, 68, 97-99) and has been described as significantly contributing to the chronic 
disease burden in South Africa (13, 38). The high prevalence of NCDs in the current study is a 
reflection of the ongoing health transition attributed to lifestyle changes and has been suggested 
to also be related to the expanded ARV roll-out in South Africa (4, 13, 38). 
Key findings 
 High prevalence of self-reported NCDs in the population 
 Low prevalence of self-reported HIV/AIDS in the population 
 HIV/AIDS and NCDs were the main predictors of healthcare utilisation in the 
population aged 50 years and older  
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Self-report of HIV/AIDS was low (3%), and well below the local HIV prevalence among adults 
(17%) as recently estimated in the study site (100); 2010 national estimate (10.5%) (101); and 
2014 national estimate (14). This suggests significant under-reporting of HIV infection, possibly 
related to stigma associated with HIV infection (102). 
 
Similar to other studies in LMICs showing education as a strong predictor of use of facility-
based maternal health services (103-105), and consistent with evidence in the literature showing 
that higher education is an important determinant for positive behavior or motivation toward 
HCU (105), this study showed that having more years of education was associated with higher 
healthcare utilisation 
 
Perhaps the reasons for which NCDs and HIV/AIDS predicted healthcare utilisation were 
because of the high prevalence of these chronic conditions in the study setting (98, 100), and the 
fact that most of the healthcare utilisation occurred in the public health facilities (the largest 
group utilised in the study setting). This may have implications for South Africa‘s primary 
healthcare system, which is yet to adapt to not only long-term continuity of care for patients 
living with chronic diseases (4) mostly in the public sector but also to prepare for increasing 
utilisation by those who are not yet accessing chronic disease services. Despite the higher self-
reported prevalence of NCDs than HIV/AIDS, the latter was a stronger predictor of healthcare 
utilisation. This may be explained by significant  under-reporting of HIV infection possibly 
related to stigma associated with HIV infection (102) and the general low level of awareness of 
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hypertension (106) due to the lack of symptoms among diagnosed individuals. Furthermore, 
those who reported being infected with HIV were already engaged in the healthcare system. 
 
Fifty years was adopted as the cut-off for defining older age in this study, in line with the cut-off 
that has been used in the Study on Global Ageing and Adult Health (SAGE) (107) in the study 
setting and aligned with the cut-off set for the Minimum Data Set (MDS) project on ageing - 
supported by the World Health Organization (WHO) and the U.S National Institute on Ageing - 
to refer to the older population in Africa (108, 109). Although there is no United Nations (UN) 
standard numerical criterion for old age, the agreed cut-off for defining old age is generally 60 
years and above (109). The chronological age of 60 or 65 is said to be the beginning of old age in 
most developed countries because it is roughly equivalent to retirement age (110). In Africa, the 
majority of older people do not expect formal retirement or retirement benefits because they live 
in rural communities and earn a living outside the formal sector (109). Southern Africa is the 
region with the highest prevalence of HIV/AIDS in the African continent. Life expectancy has 
decreased from 61 years in 1990-1995 to 52 years in 2005-2010 in this region due to the impact 
of HIV/AIDS, and is not expected to recover from the pre-1990 levels until 2045 (111).  
 
The Minimum Data Set (MDS) project on Ageing - supported by the World Health Organization 
(WHO) and the U.S National Institute on Ageing - has set 50 years and above as the cut-off to 
refer to the older population in Africa (108, 109).  The same cut-off has been used in the Study 
on Global Ageing and Adult Health (SAGE) (107). Given these background information and and 
the evidence that the global population of persons aged 50 and over is expected to increase from 
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21% to 34% in 2050 (111), this thesis adopts 50 years and above to describe the population of 
older adults. 
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5.2 Quality of care in the ICDM model 
Key findings 
Quantitative study 
 Operational managers reported satisfaction with all dimensions of care in the 
ICDM model except patient waiting time. 
 Patients reported satisfaction with all dimensions of care in the ICDM model 
except appointment system, defaulter tracing of patients and patient waiting 
time. 
 Availability of equipment, supply of critical medicines and accessibility of care 
(structure dimensions) directly influenced the ability of nurses to attend to 
patients‘ needs, be professional and friendly (process dimensions). These 
process factors directly influenced coherence of care, competence of nurses and 
patients‘ confidence in the nurses (outcome dimensions). These structure 
factors directly influenced outcome dimensions of care. 
 Of the eight priority areas, supply of critical medicines and coherence of care 
were significantly associated with good quality of care. 
Qualitative study 
 Nurses thought there was reduced HIV-related stigma because patients 
receiving treatment for HIV and NCDs attended the same clinic. 
 Nurses reported the use of traditional haelers by patients 
 Patients reported HIV stigma due to defaulter tracing activities of home-based 
carers in the community 
 Patients reported involvement of government nurses in private commercial 
activities during work  
 Nurses and patients reported occasional anti-hypertension drug stock-outs, 
malfunctioning blood pressure machines, staff shortage, dysfunctional 
prepacking of drugs and long patient waiting time. 
 Nurses and patients reported diverging opinions on defaulter tracing activities 
rigid clinic appointments and defaulter tracing activities. 
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The operational managers in this study reported satisfaction with 16 of the 17 dimensions of care 
in the quantitative sub-study on quality of care in the ICDM model, but this was less so for the 
patients who reported satisfaction with 14 dimensions of care. The significant differences in the 
satisfaction scores of the patients and operational managers in this sub-study supports evidence-
based literature that suggests assessing satisfaction with quality of care from provider and patient 
(112) because of differing views (81). The patients rated satisfaction with the availability of 
equipment higher than the operational managers rated satisfaction. A possible explanation of this 
difference in satisfaction rating could be attributed to the fact that patients may not be fully 
aware of the lack of equipment such as sphygmomanometers, or their non-functionality or the 
low quality of the existing ones (113). The patients‘ satisfaction scores for friendliness of the 
nurses and physical examination of patients was higher than those of the operational managers. 
The operational managers who responded to the interviews are professional nurses who often 
perform a dual role of providing routine care to the patients and managing the facilities. In the 
course of performing their administrative duties in the office, these managers may not have the 
opportunity to see the professional nurses being friendly to patients in the consultation rooms. 
This may have accounted for the managers‘ lower satisfaction scores compared with the patients‘ 
scores.   
 
The use of a qualitative method to triangulate data collection yielded in part results that were 
discrepant from those reported by patients in the quantitative sub-study on quality of care. In the 
qualitative part of the study, patients reported anti-hypertension drug stock-outs, malfunctioning 
blood pressure machines, dysfunctional prepacking of drugs, lack of confidentiality in defaulter-
tracing activities, unprofessional conduct of nurses, rigid clinic appointment systems and long 
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patient waiting time. This is contrary to the high patient satisfaction scores observed in the 
quantitative part of the study, an indication that the patients were more at ease to express 
themselves in the FDGs compared to the quantitative survey. 
 
Patient waiting time was the only dimension of care in the ICDM model in which the patients 
and operational managers unanimously reported low satisfaction scores. Similar studies 
assessing the quality of service in public clinics in South Africa showed that the clinics were 
easily accessible and services were of acceptable quality (114), but the time spent by patients at 
the clinic to complete the services was very long (114, 115). These findings suggest that public 
health services in South Africa, like in many resource-constrained LMICs, are characterised by 
long waiting times (116-118), which could be a consequence of operational challenges, such as 
performance of multiple tasks and work overload of health workers (112). In addition to staff 
shortage which was reported by operational managers and patients, the qualitative study on the 
quality of care in the ICDM model showed that patients who missed previous clinic 
appointments were being made to wait in the queues during subsequent visits until nurses had 
attended to patients who were on the appointment list for that day. Other factors reported by 
patients as contributing to long waiting time in the qualitative study were late arrival of filing 
clerks and nurses; long morning prayer sessions before commencement of clinical duties; staff 
meetings; prolonged tea or lunch breaks; and nurses giving preferential treatment to friends or 
relatives who skip the queues. These trading activities which are not related to professional work 
could potentially contribute to long patient waiting time in the clinics. Furthermore, preferential 
treatment to health workers‘ friends and relatives could also lead to patient dissatisfaction with 
services and prolonged waiting time. Therefore, educational programmes need to be targeted at 
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healthcare workers to change their attitudes and behaviours regarding the provision of quality 
services to patients.  
 
Many African countries witnessed reductions in HIV-related prejudicial attitudes following ART 
rollout (119, 120). However, HIV stigma persists and remains a barrier to HIV treatment and 
care in South Africa (121, 122). Although it has been widely reported in the literature, the HIV-
related stigma reported in the communities in this study can be considered to be an unintended 
consequence of the ICDM model, through the defaulter-tracing activities of HBCs, and has the 
potential to negatively impact the effectiveness of the model in improving patients‘ health 
outcomes. Furthermore, the use of traditional healers may interfere with pharmaceutical 
treatment which could result poor health outcomes of the patients. 
 
One of the substantive findings obtained both by quantitative and qualitative methods in terms of 
how quality of care is conceptualised is the diverging views of providers and patients. Nurses 
and patients had high and low satisfaction scores in appointment systems and defaulter-tracing 
activities, respectively. Constraints experienced by each group (e.g. providers working under 
pressure due to chronic staff shortage, patients struggling to access services or their lack of trust 
in service providers) in the qualitative study may have led to a these different views on quality of 
care; hence, the need to address these challenges patients and healthcare workers face through a 
people-centred health system.   
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The healthcare provider-user interface reported in the quantitative sub-study corroborates  the 
multi- and bi-directional relationship between structure, process, and outcome constructs 
postulated by Avedis Donabedian (59). Using satisfaction scores of service users, the patients‘ 
perception of quality of care in the ICDM model can be interpreted to mean that the provision of 
good structure (availability of functional equipment, supply of critical medicines, accessibility of 
chronic disease care) directly promotes good outcome (coherent chronic disease care, 
competence of nurses and patient confidence in nurses); and that the relationship between good 
structure and good outcome is mediated by good process (attendance to patients‘ needs, 
professional conduct of nurses and nurses‘ friendliness to patients).  
 
In the qualitative part of the study, staff shortage and the lack of prepacking bags (structure 
factors) made it challenging for nurses to prepack patients‘ drugs (process factor) which in turn 
led to long patient waiting time (outcome factor). Patients who missed clinic appointments 
(process factor) felt nurses were unfriendly (process factor) to them during their subsequent 
clinic visit and punished them by delaying their consultation process (outcome factor). These 
dynamics contributed to avoidable long waiting periods (outcome factor), aside from other health 
facility-related factors, such as the late arrival of staff; long morning prayer sessions before 
commencement of clinical duties; morning staff meetings; and prolonged tea/lunch breaks. The 
positive and negative relationships in the SPO constructs observed respectively in the 
quantitative and qualitative part of the study highlight the need to use mixed methods to 
triangulate data in quality of care studies. 
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The municipal health manager reported availability of an ICDM treatment manual for the 
management of chronic disease when interviewed on the availability of an ICDM policy to create 
an enabling environment for the operational implementation of the ICDM model. Whether an 
ICDM policy was available in the municipality and the Provincial or National Departments of 
health could not be ascertained following the failure to receive permission to conduct a key 
informant interview with senior officers in the Department of Health in Mpumalanga province. 
 
The race of the FGD participants reflects the dominance of black people in the study setting 
(Table 3). The gender imbalance of the participants in the FGDs (15 males and 41 females) 
corroborates the gender constitution of the population in the study setting (Table 3 - female vs. 
male: 70% vs. 30%) and the gender composition of the 345 patients from which the FGD 
participants were recruited (Table 7 - female vs. male: 83% vs. 17%). 
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5.3 Changes in patients’ health outcomes attributable to the ICDM model 
 
 
 
 
The reduction in the decreasing trend for the control of CD4 counts observed in both study arms 
six months before the initiation of the ICDM model may be attributed to the existing vertical 
HIV programme. The latter has expanded access to ART in LMICs (123), particularly in South 
Africa which has the world‘s largest ART programme (124), with consequent improvement in 
health outcomes and increasing life expectancy (14). The ICDM model seemed to have enhanced 
the existing ART programme by cutting back on the downward trajectory in the control of CD4 
counts in the post-intervention period. The lower rate of decline in the control of CD4 counts in 
the pilot than in the comparison facilities may have been due to reduced HIV stigma which was 
reported by operational managers in the qualitative sub-study of our broader research (Ameh et 
al., under review). This may have impacted positively on CD4 counts because HIV and NCD 
patients received care in the same consultation rooms as was reported in a Cambodia pilot study 
(2, 19). 
 
The Cambodian study (19) provided early research evidence that informed the UNAIDS‘ 
recommendation of an integrated management approach to leverage positive lessons learned 
from HIV/AIDS programme to support or scale-up services for NCDs (2). Our study 
Key findings 
 In the post-intervention period, the ICDM model appeared to have decreased 
the downward trajectory in the control of CD4 counts and blood pressure 
observed in the period before the initiation of the model. However, there was 
no overall clinical benefit for the patients. 
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corroborates the Cambodian study by demonstrating the feasibility of an integrated approach for 
the management of HIV and NCDs, specifically hypertension, in South Africa. Although the 
WHO recommends virological monitoring as the preferred approach to treatment monitoring for 
those on ART (125), we used CD4 counts as the indicator for assessing the effectiveness of the 
ICDM model in improving health outcomes of patients receiving ART. This is because viral load 
measurements were repeated in the study facilities annually compared with CD4 counts which 
were repeated every three to six months. Therefore, analysis of the viral load data posed a 
limitation because more data points were needed to undertake segmented regression analysis. 
Furthermore, CD4 counts are still important indicators for initiating and monitoring ART (126) 
and HIV disease progression (127) in resource-limited settings such as South Africa. 
 
Optimal BP control is difficult to achieve (36, 128-132). Although there was a reduction in the 
decreasing trend for BP control, the suboptimal control of BP observed in the pilot facilities 
implies that the purpose for which the ICDM model was initiated - to leverage HIV programmes, 
tools and systems to scale up services for NCDs - is yet to be fully achieved. The failure to 
achieve optimal BP control in the study setting may in part be attributed to the condition of the 
health system and individual factors.   
 
Four health system factors may have negatively impacted optimal BP control in this study. First, 
a study conducted at the time the ICDM model was initiated revealed that South Africa‘s public 
health sector vertical HIV programme was not administratively integrated with the horizontal 
general health system (18). Horizontal managers at the district and sub-district levels exercised 
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little authority in using HIV data, while vertical managers used HIV data in silos within the HIV 
sub-programmes (18). Therefore, full administrative or operational integration of HIV services 
with those of NCDs may be far from being achieved. Secondly, a quantitative component of  our 
broader study (Ameh et al., under review) showed that five of the eight dimensions of care 
(referral system, defaulter tracing, prepacking of drugs, appointment system, and long patient 
waiting time) identified as the priority areas in the ICDM model were not significantly associated 
with good quality of care in the pilot facilities. These priority areas are the components of the 
HIV programme that are being leveraged to improve the quality of services for NCDs in the 
ICDM model. It is recommended that the ICDM model programme managers and service 
providers in the health facilities should focus on improving the quality of care in these priority 
areas for better health outcomes for NCD patients. The third reason for poor BP control may 
have been due to ineffective titration of treatment, as was reported by Basu et al. in the SAGE 
study (128).  
 
Finally, the qualitative component of our broader study showed that facility managers and 
patients reported that nurses were overburdened by an increased workload resulting from 
integrated services. Furthermore, staff shortage, malfunctioning blood pressure machines and 
antihypertensive drug stock-outs were reported by patients and facility managers in these 
facilities (Ameh et al., under review). These suboptimal structure- and process-related factors 
could be considered unintended consequences of the ICDM model that may have resulted in 
suboptimal blood pressure control. Achieving optimal health outcomes in the ICDM model will 
require strengthening the health system in South Africa. Therefore, health system interventions 
that focus on improving performance of the structural/hardware or social/software components 
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of the health system‘s building blocks (e.g. governance, human resources, service delivery and 
medicines and technologies) are needed to strengthen South Africa‘s PHC system in which the 
ICDM model is embedded (44). 
 
Individual-level factors that may have contributed to  sub-optimal BP control in our study 
included ignorance of the complications of high BP; obesity and physical inactivity (130); poor 
adherence to pharmacological (131, 132) and non-pharmacological treatment; and low socio-
economic status (132). This suggests that South Africa‘s health system needs to be strengthened 
through a people-centred model that addresses increased awareness of health promoting 
activities and the complications of poor compliance with treatment; and better patient self-
management (44). 
 
Although proportionate sampling was done using the facility rosters, the study arms were 
different in age distribution with the pilot facilities predominantly composed of people 50 years 
and older, whereas, the comparison facilities were made up of people younger than 50 years. 
This age difference may have accounted for the higher number cases of hypertension patients in 
the pilot facilities and more HIV patients in the comparison facilities. The difference in the age 
structure was standardised in the data analysis by the use of propensity score matching in order 
to minimise the potential for biased results.  
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Based on empirical evidence from the data, I am not aware of factors that may have accounted 
for the drop in the probability of controlling CD4 counts and BP before the implementation of 
the ICDM model in both study arms. Health system factors common to both study arms may 
have been responsible for the declining control of CD4 counts and BP  because these facilities 
were being managed by the same administrative and managerial structures in the municipality. 
Further research is needed to better understand the factors predicting the poor control of CD4 
counts and BP before the implementation of the ICDM model. The decline in the control of CD4 
counts and BP in the pilot facilities was steeper than the decline in the comparison facilities. This 
may have been due to a crowding-out of routine training activities which typically occur before 
or during the implementation of an intervention programme as was the case in the pilot facilities 
(44).  
My doctoral study was the first facility-based non-interventional research to be conducted in the 
Agincourt HDSS. Observational work (e.g. monitoring of vital events and residency status) has 
been ongoing in the Agincourt HDSS site since 1992. These studies focus on different stages 
along the life course; evaluation of national policy at population, household and individual 
levels; and examination of household responses to external shocks and their effects on health and 
well-being. More recently, population-based trials promoting psychosocial well-being, 
preventing HIV transmission and reducing metabolic risk of metabolic diseases have targeted 
children and adolescents (61, 63). It is important to underline that although the population 
receiving treatment in the pilot facilities has been under surveillance for nearly two decades, the 
impact of the Agincourt HDSS on the operations of the health facilities is minimal because the 
MRC/Wits Agincourt Unit does not manage the ICDM pilot facilities.  
 
 124 
 
In this study, comparative data were not available on staffing and patient load in the ICDM pilot 
and comparison facilities. However, analysis of the qualitative data showed that patients reported 
malfunctioning BP machines and antihypertensive drugs stock-outs, while stock-outs of ART 
were rarely reported (Ameh et al., under review). This may have accounted for the difference in 
the nature of care relating to the control of CD4 counts and blood pressure.  
 
Patients who received care in the ICDM pilot facilities had a different age structure and chronic 
disease profile from those in the comparison facilities. The majority of those in the ICDM pilot 
sites were hypertensive and ≥ 50 years while the majority of the study participants in the 
comparison facilities were below < 50 years of age and living with HIV. These observed 
differences in age and disease profiles could be a reflection of the dynamics between age and 
labour patterns. Three of the five communities served by the comparison facilities have 
contiguous boundaries with semi-urban towns; hence, the attraction of a young labour workforce 
to these towns. This sets the stage for young people residing permanently in the aforementioned 
three villages to travel daily or migrate temporarily to work in these semi-urban towns. 
Temporary migration of this nature has been reported to be associated with HIV infection (71), 
potentially accounting, therefore, for the higher number of younger people living with HIV in the 
comparison facilities. This is in contrast to the typically rural communities served by the ICDM 
pilot facilities. Out-migration from these communities, which is predominantly accounted for by 
younger people in the 35-54 age group, may have resulted in a disproportionately higher number 
of older people permanently resident in these rural communities (63). The higher prevalence of 
hypertension among the patients who received care in the ICDM model facilities may have been 
due to the reported trend in out-migration from the communities served by these facilities. A 
 125 
 
previous study in these rural communities also reported a high prevalence of cardiovascular 
diseases (98) which corroborates the findings of our research. 
5.4 Linkages between study findings and conceptual framework 
The ―Vunene study‖ findings revealed how the roles and activities of relevant stakeholders and 
patient-nurse interactions influenced patients‘ perception of the quality of care at the meso-level. 
Patients thought that half of the 17 dimensions of care offered in the ICDM pilot facilities were 
of good quality. An objective assessment of patients‘ health outcomes at the micro-level showed 
a decrease in the downward trajectory in the control of CD4 counts and blood pressure observed 
in the period before the implementation of the model. Policy analysis at the macro-level to 
examine the role of an ICDM policy in creating an enabling environment towards improved 
quality of care and patients' health outcomes was not feasible and needs further research.  
5.5 A critical appraisal of Avedis Donabedian’s theoretical framework 
Although Donabedian‘s unidirectional framework continues to be the dominant touchstone 
paradigm for assessing the quality of health care, it has been described as too linear to recognise 
complex interactions between SPO constructs (59). Donebedian‘s critics argue that his theory 
fails to incorporate patient characteristics which are important precursors in the evaluation of the 
quality of health services (133). However, these limitations do not affect the validity of our study 
for the following reasons. First, the linearity of Donabedian‘s theory forms the basis of our study 
which assesses the linearity of the relationships between structure, process, and outcome 
constructs through the specified unidirectional, mediation and reciprocal pathways. The linearity 
of Donabedian‘s theory would have been a limitation in our study if we sought to determine non-
linear relationships between SPO constructs . Regarding the limitation of Donabedian‘s theory 
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not accounting for patients‘ socio-demographic characteristics, it is important to note that 
patients‘ characteristics cannot be categorised as dimensions of care under SPO constructs in the 
ICDM model. This is because patients‘ characteristics do not fit into Donebedian‘s definition of 
SPO constructs and therefore have no role to play in explaining Donabedian‘s theory of quality 
of care; hence, the rationale for selecting his theoretical framework for evaluating the quality of 
care in the ICDM model.  
5.6 Study limitations 
Limitations of these studies have been categorised into selection and measurement bias. 
5.6.1 Selection bias 
Exclusion of people younger than 50 years of age, the age category most at risk of HIV/AIDS 
may have resulted in the low prevalence of self-reported HIV/AIDS in the healthcare utilisation 
study. There were differences between responders and non-responders in the HCU sub-study. 
Presenting the data for responders could be a source of selection bias. In the ICDM model study, 
inferences could not be made about the (dis)satisfaction of other professional nurses with 
services in the ICDM model, due to the small number of operational managers who were 
interviewed. All the studies in this thesis were conducted in a rural municipality of South Africa 
and our findings may not be reflective of PHC facilities in urban municipalities in Gauteng, 
Mpumalanga and North West provinces where the model is also being piloted. 
5.6.2 Measurement bias 
In the healthcare utilisation study, there may have been recall bias among study participants in 
reporting their experiences with healthcare in the period of 12 months before the survey was 
conducted.  Although the qualitative research helped to identify contextual factors that could 
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contribute to understanding the quality of care provided in the ICDM model for the purpose of 
generating recommendations for policy and practice, it does not allow us to establish cause and 
effect relationships. Study findings in the secondary analysis of health outcome data retrieved 
from clinic records must be interpreted in the light of the limitations imposed by the use of 
routine healthcare data. More specifically, some facility-level data were incomplete or 
unavailable due to one or more of the following reasons: (1) missing laboratory results of CD4 
counts and viral load and (2) missing records of BP measurements due to BP machines being out 
of order. Other limitations included the paucity of information on facility-level factors such as 
comparative data on staffing, patient load, medication supply chain, and our inability to obtain at 
least eight data time points (e.g. eight months) before the implementation of the ICDM model 
due to the unavailability of  notebooks in which patients‘ clinical information were recorded. 
Most of these home-based notebooks were not in the facility records before January 2011 and 
may have been lost or misplaced during the process when patients transported the notebooks (in 
transit) between the homes and the health facilities.  
5.7 Study strengths and contribution to knowledge 
To the best of my knowledge, this is the first study in sub-Saharan Africa to evaluate the quality 
of care in the ICDM model and assess the effectiveness of the model in improving key health 
outcome indicators of patients receiving treatment for hypertension and HIV in PHC facilities. 
We are not aware of any studies that have applied Donabedian‘s theoretical framework for 
evaluating the ICDM model which is a major initiative of the NDoH in South Africa. Hence, this 
thesis contributes to the national and global debates on an integrated health systems approach for 
the management of chronic diseases.  
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In my view, the use of quantitative and qualitative methods to triangulate the data and methods 
was a major methodological strength of this thesis. Two types of triangulation were implemented 
in the studies that make up this thesis: methodological triangulation, in which more than one 
method (quantitative and qualitative) was used to gather data; and data triangulation involving 
collecting data from different population subsets at different time and space (134). A 
combination of methodological and data triangulation enhanced validity of the quality of care 
study in this thesis. 
 
The qualitative method used was well suited to the study because of the dearth of contextual 
qualitative data on provider-patient perspectives on the quality of care in the ICDM model. The 
use of a combined deductive and inductive approach in collecting and analysing the qualitative 
data was also a major feature in this thesis. 
5.8 Conclusion 
HIV and NCDs were the main health problems and predictors of HCU in the population aged 50 
years and older prior to the introduction of the ICDM model in 2011, suggesting the 
prioritisation of public healthcare services for chronic diseases among older people in this rural 
setting. In the quantitative study on quality of care, five of the eight priority areas used as 
leverage for the control of NCDs (referral, defaulter tracing, prepacking of medicines, clinic 
appointments and waiting time) did not reflect their intended constructs; hence, the need to 
strengthen services in these areas. In the qualitative study on quality of care, nurses and patients 
reported occasional anti-hypertension drug stock-outs, malfunctioning blood pressure machines, 
staff shortage, dysfunctional prepacking of drugs and long patient waiting time. Nurses thought 
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there was reduced HIV-related stigma because patients receiving treatment for HIV and NCDs 
attended the same clinic, whereas patients reported HIV stigma due to defaulter tracing activities 
of home-based carers in the community. Nurses and patients reported diverging opinions on 
defaulter tracing activities rigid clinic appointments and defaulter tracing activities. Nurses 
reported the use of traditional haelers by patients 
 
Although the ICDM model did not reverse the downward trajectory in the control of CD4 counts 
and BP, it saw in the post-intervention period a decline in the worsening trend in the control of 
CD4 counts and blood pressure observed in the pre-ICDM model period. This implies that more 
time is needed to more effectively leverage the priority areas in the HIV treatment programme 
for NCDs in order to produce an upward trajectory in the control of patients‘ CD4 counts and 
BP. Suboptimal BP control observed in this study may have been due to poor quality of care in 
the identified priority areas of the ICDM model and unintended consequences of the model such 
as work overload, staff shortage, malfunctioning BP machines and anti-hypertension drug stock-
outs.  
 
An ideal clinic in a re-engineered PHC system that complies with the national core quality 
standards through provision of good quality chronic disease care (meso-level) that leads to 
optimal patient‘s health outcomes (micro-level) could be achieved in South Africa if the 
aforementioned health system challenges are adequately addressed.  
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5.9 Implications for future research 
Future research is needed to better understand factors other than the ICDM model that may be 
associated with changes in patients‘ health outcomes.  Further research is also needed to 
understand how the ICDM model is operationalised in urban PHC facilities and how effectively 
it serves to address tuberculosis, a chronic communicable disease, and other NCDs (e.g. diabetes, 
chronic obstructive pulmonary diseases, asthma, epilepsy and mental illnesses) prioritised in the 
ICDM model. 
5.10 Policy implications 
Although the ICDM approach appears to have reduced a declining trend for CD4 counts and 
blood pressure control in our study setting, the primary purpose of using the HIV programme as 
leverage for scaling up services for NCDs, specifically hypertension, is yet to be fully achieved. 
This is critical for the nationwide implementation of the ICDM model in all PHC facilities and 
the wider policy reforms around the PHC re-engineering and ―Operation Phakisa Ideal Clinic 
Realisation and Maintenance Programme‖ currently underway in South Africa. Hence, there is a 
need to more effectively leverage the vertical HIV treatment programme for NCDs through the 
role and activities of the WBOTs (Ward-based Outreach Teams) and DCSTs (District Clinic 
Specialist Teams). The WBOTs will need to perform more screenings to increase the awareness 
of hypertension and other NCDs in the population and interact more directly with the community 
to ensure continuity of care. The DCSTs have to more effectively supervise the processes of care 
and perform more clinical audits of services provided by the ward-based outreach and integrated 
school health teams.  
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Another key finding from this research is that health system factors such as malfunctioning blood 
pressure machines, staff shortage, and anti-hypertension drug stock-outs need to be addressed in 
order to achieve the expected optimal benefits of the ICDM model in improving patients‘ health 
outcomes. System-level interventions targeting specific building blocks of the health system such 
as governance, human resources, service delivery, and medicines and technologies are needed to 
strengthen South Africa‘s PHC system in which the ICDM model is embedded. 
The findings of the body of work in this thesis could have policy relevance for Uganda, Kenya, 
Ethiopia, Swaziland and perhaps other LMICs currently undertaking proof of concept studies to 
demonstrate the feasibility of planning and implementing an integrated chronic disease care 
model.  
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Appendix 1: Short-form of Patient Satisfaction Questionnaire (PSQ-18) (80) 
 
Listed below are some things people say about healthcare. Please read each one carefully, 
keeping in mind the healthcare you are receiving now. (If you have not received care recently, 
think about what you would expect if you needed care today.) We are interested in your 
feelings, good and bad, about the healthcare you have received. The phrase ―healthcare 
provider‖ includes physicians, physician assistants and nurse practitioners. 
 
How strongly do you AGREE or DISAGREE with each of the following statements? (Circle One Number on Each 
Line) 
 
1. Healthcare providers are good about explaining the 
reason for medical tests (P1). 
     
2. I think my healthcare provider‘s office has everything 
needed to provide complete medical care (S1).a 
     
3. The healthcare I have been receiving is just about perfect (O1).b      
4. Sometimes healthcare providers make me wonder if their 
diagnosis is correct (O3). 
     
5. I feel confident that I can get the healthcare I need without being 
set back financially (D1). 
     
6. When I go for healthcare, the provider is careful to check 
everything when treating and examining me (P11). 
     
7. I have to pay for more of my healthcare than I can afford (D2).      
8. I have easy access to the medical specialists I need (P5 & P6).c      
9. Where I get healthcare, people have to wait too long for 
emergency treatment (O4). 
     
10. Healthcare providers act too businesslike and impersonal toward 
me (P3).d 
     
11. My healthcare provider treats me in a very friendly and 
courteous manner (P4). 
     
12. Those who provide my healthcare sometimes hurry too much 
when they treat me (P13). 
     
13. Healthcare providers sometimes ignore what I tell them (P2).      
14. I have some doubts about the ability of the healthcare 
providers who treat me (O5). 
     
15. Healthcare providers usually spend plenty of time with 
me (P12). 
     
16. I find it hard to get an appointment for healthcare right 
away (P14). 
     
17. I am dissatisfied with some things about the healthcare I 
receive (O2).e 
     
18. I am able to get healthcare whenever I need it (S4).      
 
a
Rephrased to reflect availability of functional equipment for chronic disease care (structure - S1) 
b
Rephrased to reflect satisfaction with coherence of integrated chronic disease care (outcome - O1)  
c
Statement changed to reflect referral of patients to the hospitals (process - P5 and P6)  
d
Statement changed to reflect professional conduct of the nurses during clinical duties (process - P3)  
e
Rephrased to reflect dissatisfaction with coherence of integrated chronic disease care (outcome - O2)  
     
Agree Agree Uncertain Disagree  
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Appendix 2a: Sampling of the study participants in the ICDM pilot facilities 
 
Health 
facilities 
Number of patients recorded 
in the clinic appointment 
roaster in July 2013. 
*Step 1 sampling: 
proportionate sampling 
from the health facilities 
**Step 2 sampling: 
proportionate 
sampling by chronic 
disease status  
ART HPT DM Total ART HPT DM 
A 724 642 - 1366 165 88 77 0 
B 146 715 - 861 104 18 86 0 
C 41 325 7 373 45 5 39 1 
D 84 274 6 364 44 10 33 1 
E 66 50 - 116 14 8 6 0 
F 50 215 - 265 32 6 26 0 
G 49 208 - 257 31 6 25 0 
Total 1160 2429 13 3602 435 141 292 2 
#
ART, HPT and DM = HIV/AIDS, hypertension and diabetes mellitus patients, respectively.  
*Step 1: proportionate sampling for each health facility was achieved by multiplying the 
sampling fraction by the total number of patients in each health facility 
Sampling fraction = 435/3602 = 0.1207 
Where 435 = calculated study sample size and 3602 = total sampling frame  
Example of proportionate sampling for clinic A: 0.1207 x 1366 = 165, where 1366 is the total 
number of patients in health facility A. 
**Step 2: proportionate sampling in each health facility 
Example of proportionate sampling in health facility A 
53% (724/1366) and 47% (642/1366) of the total number of patients in health facility A were 
HIV and hypertension patients, respectively. Of the 165 patients recruited in health facility A, 
53% (n=88) were HIV patients and 47% (n=77) were hypertension patients. 
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Appendix 2b: Sampling of the study participants in the comparison facilities 
 
Health 
facilities 
Number of patients recorded 
in the clinic appointment 
roaster in July 2013. 
*Step 1 sampling: 
proportionate sampling 
from the health facilities 
**Step 2 sampling: 
proportionate 
sampling by chronic 
disease status  
ART HPT DM Total ART HPT DM 
A 365 115 - 480 58 44 14 0 
B 231 175 - 406 49 28 21 0 
C 107 125 - 232 28 13 15 0 
D 233 156 - 389 47 28 19 0 
E 1426 713 22 2161 261 173 86 2 
Total 2362 1284 22 3668 443 286 155 2 
#
ART, HPT and DM = HIV/AIDS, hypertension and diabetes mellitus patients, respectively.  
*Step 1: proportionate sampling for each health facility was achieved by multiplying the 
sampling fraction by the total number of patients in each health facility 
Sampling fraction = 443/3668 = 0.121 
Where 443 = calculated study sample size and 3668 = total sampling frame  
Example of proportionate sampling for clinic A: 0.121 x 480 = 58, where 480 is the total number 
of patients in health facility A. 
**Step 2: proportionate sampling in each health facility 
Example of proportionate sampling in health facility A 
76% (365/480) and 24% (115/480) of the total number of patients in health facility A were HIV 
and hypertension patients, respectively. Of the 58 patients recruited in health facility A, 76% 
(n=44) were HIV patients and 24% (n=14) were hypertension patients. 
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Appendix 3: The adapted satisfaction questionnaire administered to patients attending health 
facilities in the Agincourt sub-district in 2013 
 
Labels Statements 
Structure 
S1 
S2    + 
S3    - 
S4     
   
Process 
P1 
P2 
P3 
P4 
P5    + 
P6    - 
P7    + 
 
P8    - 
P9     + 
P10   - 
P11 
P12   + 
P13   - 
P14 
 
Outcome 
O1    + 
O2    - 
O3 
O4 
O5 
 
Dropped 
D1    +  
D2    - 
 
I think my healthcare providers have functional equipment to provide complete chronic disease care 
I think this health facility has regular supply of medicines for the treatment of my illness
a
 
I think this health facility does not have regular supply of medicines for the treatment of my illness
a
 
I am able to get healthcare whenever I need it 
 
 
Healthcare providers are good about explaining the reason for medical tests 
Healthcare providers sometimes ignore what I tell them 
Healthcare providers are professional in the conduct of their clinical duties 
My healthcare providers treat me in a very friendly and courteous manner 
Healthcare providers usually refer me to the hospital when there is need for the doctor to review me
a
 
Healthcare providers do not refer me to the hospital when there is need for the doctor to review me
a
 
When I miss clinic appointment(s), the Community (volunteer) Health Workers visit my house to ask 
why I did not come to the clinic
a
 
The Community (volunteer) Health Workers do not visit my house when I miss clinic appointment(s)
a
 
Healthcare providers prepack my drugs the day before my clinic appointment(s)
a
 
Healthcare providers do not prepack my drugs the day before my clinic appointment(s)
a
 
When I visit the clinic, the providers are careful to check everything when treating and examining me 
Healthcare providers usually spend plenty of time with me 
Those who provide my healthcare sometimes hurry too much when they treat me 
I find it hard to get an appointment when I need it
b
  
 
 
I am satisfied with the quality of coherent integrated chronic disease care that I receive
b
  
I am dissatisfied with the quality of coherent integrated chronic disease care that I receive
b
 
Sometimes healthcare providers make me wonder if their diagnosis is correct 
When I come to receive healthcare, i have to wait for too long to access services
b
  
I have some doubts about the ability of the healthcare providers who treat me 
 
 
I feel confident that I can get the healthcare I need without being set back financially 
I have to pay for more of my healthcare than I can afford 
a
Priority areas of the ICDM model in South Africa 
b
Priority areas of the ICDM model in South Africa originally contained in the PSQ-18 
+ sign indicates positive statements phrased in opposite directions 
- sign indicates negative statements phrased in opposite directions 
Dropped: statements excluded from the adapted PSQ because of free PHC service offered in 
South Africa  
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Appendix 4: The adapted satisfaction questionnaire administered to the operational managers 
of the health facilities in the Agincourt sub-district in 2013 
Labels Statements 
Structure 
S1 
S2    + 
S3    - 
 
S4     
   
Process 
P1 
P2 
P3 
P4 
P5    + 
 
P6    - 
 
P7    + 
 
P8    - 
 
P9     + 
P10   - 
P11 
 
P12   + 
P13   - 
P14 
 
Outcome 
O1    + 
O2    - 
O3 
O4 
O5 
 
I think the healthcare providers have functional equipment to provide complete chronic disease care 
I think this health facility has regular supply of medicines for the treatment of chronic diseases
a
 
I think this health facility does not have regular supply of medicines for the treatment of chronic 
diseases
a
 
The patients are able to get healthcare whenever they need it 
 
 
Healthcare providers are good about explaining the reason for medical tests 
Healthcare providers sometimes ignore what patients tell them 
Healthcare providers are professional in the conduct of their clinical duties 
Healthcare providers treat chronic disease patients in a very friendly and courteous manner 
Healthcare providers usually refer patients to the hospital when there is need for the doctor to review 
them
a
 
Healthcare providers do not refer patients to the hospital when there is need for the doctor to review 
them
a
 
When patients miss clinic appointment(s), the Community (volunteer) Health Workers visit their 
houses to ask why they did not come to the clinic
a
 
The Community (volunteer) Health Workers do not visit patients‘ houses when they miss clinic 
appointment(s)
a
 
Healthcare providers prepack patients‘ drugs the day before their clinic appointment(s)a 
Healthcare providers do not prepack patients‘ drugs the day before their clinic appointment(s)a 
When patients visit the clinic, the providers are careful to check everything when treating and 
examining them 
Healthcare providers usually spend plenty of time with patients 
Those who provide healthcare sometimes hurry too much when they treat patients 
Patients find it hard to get an appointment when they need it
b
   
 
 
I am satisfied with the quality of coherent integrated chronic disease care patients receive
b
 
I am dissatisfied with the quality of coherent integrated  disease care patients receive
b
 
Sometimes healthcare providers make me wonder if their diagnosis is correct 
When patients come to receive healthcare, they have to wait for too long to access services
b
  
I have some doubts about the ability of the healthcare providers who treat the patients 
 
a
Priority areas of the ICDM model in South Africa 
b
Priority areas of the ICDM model in South Africa originally contained in the PSQ-18 
+ sign indicates positive statements phrased in opposite directions 
- sign indicates negative statements phrased in opposite directions 
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Appendix 5: Antiretroviral and antihypertensive drugs used in the study settings (96) 
ART initiation and the criteria for initiation 
Regimen  Criteria ART 
1 1. CD4 count is ≤ 350  
2. Viral load < 400 
3. Stage 3 or 4 disease, 
pregnant or breastfeeding women 
regardless of CD4 count or viral load 
Tenofovir (TDF), Lamivudine (3TC) and 
Efavirenz (EFV)  
                  OR 
Fixed Drug Combination (FDC) - 
Tenofovir/Emtricitabine/Efavirenz 
 
NB: 
1. Efavirenz (EFV) is replaced with Nevirapine 
(NVP) for patients with depression or psychosis. 
 
2. Regimen 1 is replaced with Zidovudine (AZT) 
if pregnant with depression, psychosis, known 
kidney disease, disease, hypertension or ≥ 2+ 
proteinuria and refer patient to doctor.  
2 
 
Viral load > 1000 on two occasions Lopinavir/ritonavir (LPV/r), Lamivudine (3TC) 
and AZT (if currently using TDF)  
                            OR 
TDF [if currently using AZT or Stavudine (d4T)] 
Antihypertensive and adjuvant drugs 
1 The most commonly prescribed 
antihypertensive drugs  
Hydrochlorothiazide, Enalapril, Amlodipine and 
atenolol.  
2 Adjuvant drugs prescribed for 
hypertension patients 
Daily dose of simvastatin if the patient had 
Cardiovascular Disease (CVD) or a CVD risk > 
20%  
Daily aspirin dose if patients had CVD and/or 
diabetes 
*Criteria for referral to doctor: abnormal blood results, poor adherence, TB symptoms 
depression or psychosis 
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Appendix 6: Number of monthly visits of the sampled patients who utilised primary health 
care facilities from January 2011 to June 2013 in the Bushbuckridge municipality 
Years-Months ICDM pilot facilities Comparison facilities 
 
 
Hypertension 
(n=210) 
HIV  
(n=141)  
Hypertension  
(n=91) 
HIV  
(n=282) 
2011 
   January 
   February 
   March 
   April 
   May 
   June 
   July 
   August 
   September 
   October 
   November 
   December 
 
88 
136 
137 
110 
102 
102 
96 
107 
118 
136 
119 
105 
 
17 
23 
19 
10 
29 
69 
26 
12 
21 
21 
16 
18 
 
18 
51 
52 
23 
28 
40 
54 
41 
27 
50 
29 
28 
 
15 
16 
12 
18 
31 
32 
11 
18 
18 
36 
16 
30 
2012 
   January 
   February 
   March 
   April 
   May 
   June 
   July 
   August 
   September 
   October 
   November 
   December 
 
109 
141 
123 
114 
116 
124 
126 
95 
104 
117 
97 
113 
 
15 
18 
39 
13 
22 
12 
17 
13 
17 
15 
23 
15 
 
35 
33 
53 
41 
36 
29 
24 
26 
22 
25 
31 
23 
 
25 
12 
25 
41 
53 
42 
41 
53 
40 
25 
37 
62 
2013 
   January 
   February 
   March 
   April 
   May 
   June 
 
122 
128 
101 
95 
91 
92 
 
19 
24 
22 
26 
34 
12 
 
35 
26 
32 
22 
32 
28 
 
60 
34 
40 
58 
38 
29 
*Number of patients managed for hypertension or HIV 
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